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 ABSTRACT  
Characterization and modeling of the human left atrium using optical 
coherence tomography 
Theresa Huang Lye 
With current needs to better understand the interaction between atrial tissue microstructure 
and atrial fibrillation dynamics, micrometer scale imaging with optical coherence tomography has 
significant potential to provide further insight on arrhythmia mechanisms and improve treatment 
guidance. However, optical coherence tomography imaging of cardiac tissue in humans is largely 
unexplored, and the ability of optical coherence tomography to identify the structural substrate of 
atrial fibrillation has not yet been investigated. Therefore, the objective of this thesis was to 
develop an optical coherence tomography imaging atlas of the human heart, study the utility of 
optical coherence tomography in providing useful features of human left atrial tissues, and develop 
a framework for optical coherence tomography-informed cardiac modeling that could be used to 
probe dynamics between electrophysiology and tissue structure. 
Human left atrial tissues were comprehensively imaged by optical coherence tomography 
for the first time, providing an imaging atlas that can guide identification of left atrial tissue 
features from optical coherence tomography imaging. Optical coherence tomography image 
features corresponding to myofiber and collagen fiber orientation, adipose tissue, endocardial 
thickness and composition, and venous media were established. Varying collagen fiber 
distributions in the myocardial sleeves were identified within the pulmonary veins. A scheme for 
mapping optical coherence tomography data of dissected left atrial tissues to a three-dimensional, 
  
anatomical model of the human left atrium was also developed, enabling the mapping of 
distributions of imaged adipose tissue and fiber orientation to the whole left atrial geometry. These 
results inform future applications of structural substrate mapping in the human left atrium using 
optical coherence tomography-integrated catheters, as well as potential directions of ex vivo optical 
coherence tomography atrial imaging studies. 
Additionally, we developed a workflow for creating optical mapping models of atrial tissue 
as informed by optical coherence tomography. Tissue geometry, fiber orientation, ablation lesion 
geometry, and heterogeneous tissue types were extracted from optical coherence tomography 
images and incorporated into tissue-specific meshes. Electrophysiological propagation was 
simulated and combined with photon scattering simulations to evaluate the influence of tissue-
specific structure on electrical and optical mapping signals. Through tissue-specific modeling of 
myofiber orientation, ablation lesions, and heterogeneous tissue types, the influence of myofiber 
orientation on transmural activation, the relationship between fluorescent signals and lesion 
geometry, and the blurring of optical mapping signals in the presence of heterogeneous tissue types 
were investigated. 
By providing a comprehensive optical coherence tomography image database of the human 
left atrium and a workflow for developing optical coherence tomography-informed cardiac tissue 
models, this work establishes the foundation for utilizing optical coherence tomography to improve 
the structural substrate characterization of atrial fibrillation. Future developments include analysis 
of optical coherence tomography imaged tissue structure with respect to clinical presentation, 
development of automated processing to better leverage the large amount of imaging data, 
enhancements and validation of the modeling scheme, and in vivo evaluation of the left atrial 
structural substrate through optical coherence tomography-integrated catheters. 
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Chapter 1 Background and Significance 
1.1 Atrial Fibrillation 
Atrial fibrillation is the most common major cardiac arrhythmia [1] and a significant cause 
of morbidity and mortality. During atrial fibrillation, abnormal patterns of electrical activation in 
the atria cause irregular pumping of the heart, potentially leading to serious complications such as 
stroke and heart failure.  It is estimated to affect about 33.5 individuals world-wide, [2] and the 
condition is associated with a five-fold increase in the risk of stroke, [3] as well as a 1.5 to 1.9-fold 
increase in mortality risk. [4] Atrial fibrillation is also associated with substantial healthcare costs, 
with the net incremental cost per patient per year in the USA estimated to be about $8,705. [5] With 
the prevalence of atrial fibrillation only expected to increase in future years due to the aging 
population, [6, 7] atrial fibrillation poses a significant health concern. 
Despite years of research, the underlying mechanisms of atrial fibrillation remain poorly 
understood. Atrial fibrillation is initiated and maintained by a trigger and a vulnerable substrate. [8] 
However, the specific, driving mechanisms of atrial fibrillation remain under debate. Several 
hypotheses of the electrophysiological patterns underlying the mechanisms of atrial fibrillation have 
been proposed over the years, including multiple reentrant wavelets, [9] a single reentrant circuit 
with fibrillatory conduction, [10] rapidly triggering foci, [11] rotors or spiral waves, [12] and 
epicardial and endocardial disassociation. [13, 14] The substrate of atrial fibrillation involves both 
electrophysiological remodeling, such as changes in ion channel function and refractoriness, and 
structural remodeling, such as fibrosis. [8] 
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Several different features of atrial tissue have been proposed to contribute to the 
arrhythmogenic structural substrate of atrial fibrillation. Due to anisotropic electrical conduction 
along myofiber orientation, regions of complex myofiber orientation or abrupt changes in myofiber 
direction may promote reentry, [14, 15] and myofiber orientation may become altered over the 
progression of the disease. [16] Fibrosis may similarly promote the drivers of atrial fibrillation, is 
associated with atrial fibrillation remodeling, and has gained significant interest as an 
arrhythmogenic substrate. [14, 17] The accumulation of epicardial adipose tissue has been 
associated with atrial fibrillation, and adipose infiltrations into the myocardium may disrupt normal 
electrophysiological conduction. [18] Thus, understanding the tissue structure of the atria is critical 
to further delineating the mechanisms of atrial fibrillation. 
This thesis aims to improve the study of atrial fibrillation through the use of optical 
coherence tomography imaging to better define the structural substrate underlying the arrhythmia 
in the left atrium. The 3D substrate underlying atrial fibrillation mechanisms remains to be fully 
identified, limited by current imaging resolution. To better define current limitations in the imaging 
of atrial structure, however, it is first helpful to review the current methods used to treat atrial 
fibrillation. Atrial fibrillation may be treated with antiarrhythmic medicine, electrical cardioversion, 
or ablation procedures. [19] For this study, much of the focus will be on radiofrequency ablation. 
1.2 Radiofrequency Ablation 
1.2.1 Overview 
Initially demonstrated by Cox et al. [20], radiofrequency ablation has become a standard 
therapeutic approach for atrial fibrillation. The goal of radiofrequency ablation is to interrupt or 
isolate areas of abnormal electrical conduction through the creation of non-conducting lesions in 
the atria. For the time being, ablation efforts typically focus on the left atrium. To access the heart, 
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a catheter is advanced through the femoral vein of the groin, where it eventually enters the right 
atrium from the superior vena cava. From the right atrium, the catheter is inserted through the inter-
atrial septum through a procedure called transseptal puncture. The navigation of the catheter 
throughout the ablation procedure is typically guided through echocardiography and fluoroscopy, 
which are used to track the position of the catheter, identify anatomical features, and assess any 
complications that may arise. [21-23] Once within the left atrium, the standard approach for the 
placement of lesions is to encircle the pulmonary veins, called pulmonary vein isolation. This 
method has become the cornerstone of atrial fibrillation ablation since the discovery that 
arrhythmogenic, triggering ectopic beats frequently originate within the pulmonary veins. [24] 
Widely encircling the pulmonary veins with ablation lesions placed within the left atrial antrum, 
known as wide-area circumferential ablation, has been found to be an effective approach for 
pulmonary vein isolation. [25] Directly ablating within the pulmonary vein ostia has fallen out of 
favor since the observation that doing so increases the risk of pulmonary vein stenosis. [26] In 
addition to fluoroscopy and echocardiography, electroanatomical mapping, first demonstrated by 
Pappone et al. [27], is also useful for ablation guidance and lesion placement. Electroanatomical 
mapping combines anatomical information with electrophysiological measurements such as voltage 
and activation times, and allows tracking of catheter position within the cardiac chamber, typically 
through magnet-based systems. The anatomy of the cardiac chamber is constructed as a 3D shell 
and then registered with electrical measurements through sequential, catheter point-by-point 
mapping or simultaneous multielectrode mapping. Electroanatomical maps can also be used to tag 
anatomical landmarks and record the location of generated lesions. [28] The anatomical information 
provided by electroanatomical mapping systems can be improved by integration with computed 
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tomography (CT) or magnetic resonance imaging (MRI) [29], which are often carried out pre-
procedurally to assess the patient’s atrial anatomy and pulmonary vein morphology. [30] 
1.2.2 Additional Ablation Strategies 
Aside from pulmonary vein isolation, adjunctive ablation strategies have been attempted in 
an effort to improve outcomes. Ablation in patients with persistent or permanent atrial fibrillation 
often fails to provide a long-term cure, necessitating the search for additional, effective ablation 
targets.  These approaches may be based on alternative anatomical regions of interest, such as the 
application of linear lesions along the left atrial roof or the mitral isthmus. [31] However, the 
creation of linear lesions in addition to pulmonary vein isolation has failed to show an improvement 
in outcomes in clinical trials [32, 33]. Ablation based on electrophysiological patterns have also 
been investigated, including the ablation of dominant frequency, ablation of complex fractionated 
electrograms (CFAEs), ablation of non-pulmonary vein foci, ablation of scar or fibrosis, and 
ablation of rotational activity. Dominant frequency refers to the rate of atrial activation at a 
particular site, which can be measured through spectral analysis of atrial electrograms. Regions with 
higher dominant frequency have been theorized to maintain atrial fibrillation and be targets of 
interest during ablation. [34] CFAEs are typically low-voltage electrograms with highly 
fractionated potentials or with very short cycle length, and have also been believed to play an 
integral part in atrial fibrillation mechanisms and act as optimal ablation targets [35]. Both dominant 
frequency and CFAE ablation, however, have failed to show improvement for persistent atrial 
fibrillation in clinical trials [33, 36, 37]. Non-pulmonary vein triggers may be identified through the 
administration of drugs or pacing, and ablation of such sites have shown some success, although 
more investigation is needed to define the optimal approach for mapping such triggers and the value 
of the approach on outcomes. [38] Fibrosis, which causes an increased deposition of collagen within 
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the myocardium, is believed to perpetuate atrial fibrillation by altering conduction velocity and 
anisotropy, creating blocks, or acting as anchors for reentrant waves. [17, 39] Thus, regions of 
fibrosis have been proposed as effective ablation targets, and may be localized through the 
identification of low voltage regions [40] or through MRI [41]. Atrial fibrosis as imaged by delayed-
enhancement (DE) MRI was found to be associated with the recurrence of atrial fibrillation after 
ablation [42], and the DECAAF-2 clinical trial is currently being carried out to determine if the 
ablation of fibrotic regions in addition to pulmonary vein isolation can improve outcomes in 
persistent atrial fibrillation patients. Finally, the ablation of rotational activity, also known as focal 
impulse and rotor modulation (FIRM)-guided ablation, targets cyclic activations, which revolve 
around a core of approximately zero conduction velocity, as well as spontaneously firing focal 
sources. Rotors and focal sources can be mapped through the use of basket catheters. [43, 44] Body 
surface potential mapping approaches to identify rotors have also been developed. [45] The 
effectiveness of ablation of rotor and focal sources is still under investigation. [38] 
1.2.3 Remaining Challenges in Radiofrequency Ablation 
The optimal approaches for atrial fibrillation ablation remain to be well established. 
Currently, variable success after ablation has been reported, and the overall long-term, single-
procedure success rate has been estimated to be about 50%. The overall long-term, multiple-
procedure success rate has been estimated to be about 80%. [46] However, for patients with 
persistent atrial fibrillation, it has been observed that about 50% still experience arrhythmia 
reoccurrence after their final procedure. [47] Therefore, much work remains in improving the 
efficacy of ablation therapy for atrial fibrillation, especially for more advanced forms. Because 
tissue structure plays an integral part on electrophysiological patterns and the progression of 
disease, improving the understanding of atrial structure has been of interest for improving the 
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understanding of atrial fibrillation mechanisms. Further advances in imaging guidance are also 
needed to improve the identification of substrates of interest during ablation. For instance, CFAEs 
may arise from different sources, only some of which may be arrhythmogenic, but may be linked 
to underlying fibrosis. [48, 49] Low voltage areas recorded by electrocardiac electrodes may 
indicate fibrosis or may simply be an effect of thick endocardium. [50] For this reason, there has 
been significant efforts in improving the imaging of the atrium, particularly in detecting myofiber 
orientation and fibrosis. The tissue structure extracted from these images may also be incorporated 
into realistic, image-based models to further probe the effect of tissue structure on 
electrophysiological mechanisms. 
1.3 Cardiac Imaging and Modeling 
1.3.1 Atria Imaging and Electrophysiological Models 
Several different imaging and modeling approaches have been applied in research to better 
delineate the structure of the left atrium and its effect on the mechanisms of atrial fibrillation. Due 
to its thin-walled structure, details of human left atrial tissue, and in particular myofiber orientation, 
is difficult to image with commonly used imaging modalities such as MRI, CT, and 
echocardiography. With respect to realistic tissue structure, early image-based models included 
only anatomical information of the left atrium, derived from an atlas such as the Visible Human 
Project [51, 52]. Alternatively, serial sectioning of atrial tissue and high-resolution imaging of each 
slice using a digital camera has been used to quantify fiber orientation. This method has been carried 
out in sheep atria, with the resulting structural information incorporated into electrophysiological 
models to investigate the effect of fiber orientation on electrical propagation [53]. Left atrial models 
used for electrophysiological simulation and incorporating image-based anatomy from MRI or CT 
have also been developed, but with fiber orientation derived from literature registered to the models 
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[54-57]. More recently, transmural imaging of myofiber orientation over whole human atria has 
been demonstrated using diffusion-tensor MRI [58]. Contrast-enhancement MRI [59] and micro-
CT [60] have also been utilized to image myofiber orientation in human and canine atria, 
respectively, with the data incorporated into image-based models for electrophysiological 
simulation. 
In addition to myofiber orientation, other tissue features of interest include fibrosis, adipose 
tissue, ablation lesions, and myocardial sleeves of the pulmonary veins. In the past few years, 
fibrosis has gained a significant amount of interest as a substrate of atrial fibrillation, and imaging 
of fibrotic regions within atrial fibrillation patients have been carried out using delayed-
enhancement MRI, [41] as mentioned previously, and late-gadolinium enhanced (LGE) MRI [54]. 
Using LGE MRI, patient-specific atrial anatomy and fibrosis distributions have been acquired from 
atrial fibrillation patients and incorporated into models which may be useful for pre-ablation 
planning of ablation targets based on the distribution of fibrosis [61]. Additionally, fibrosis as 
identified from contrast-enhancement MRI has been incorporated into electrophysiological models 
to study the effect of fibrosis on electrical conduction [59]. Increased adipose tissue has also been 
found to be correlated to atrial fibrillation [18], although the majority of the focus has been on 
epicardial adipose tissue, which can be imaged using MRI [62] or CT [63]. Recently, however, MRI 
imaging of fat and fatty fibrosis within the myocardium of human atrial tissue has been 
demonstrated [64]. Fat within the interatrial septum has also been associated with atrial fibrillation, 
and has been imaged using MRI [65]. Imaging of ablation lesions has been demonstrated using 
MRI, which may be useful for evaluating the permanence of lesions and predicting atrial fibrillation 
reoccurrence post-ablation [66, 67]. Finally, the myocardial sleeves of the pulmonary veins play a 
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critical role in the triggering of atrial fibrillation, and imaging of the thickness of pulmonary vein 
layers have been carried out using intravascular ultrasound [68, 69]. 
1.3.2 Optical Mapping 
It is useful to correlate structural characteristics to experimental electrophysiological 
measurements. In particular, optical mapping is a popular method with which to track the 
propagation of electrical propagation in cardiac tissue through the use of voltage-sensitive 
fluorescent dyes. Correlation of optical mapping measurements to imaged tissue features such as 
fiber orientation and fibrosis have enabled some insights on the impact of these features on 
arrhythmia mechanisms. Optical mapping measurements have also been used to inform 
electrophysiological model parameters or validate simulated results [15, 59]. However, because 
the optical mapping signal, captured only from the fluorescence that exits the tissue’s surface, 
integrates fluorescence that originates from multiple depths, optical mapping signals may have 
altered morphology when compared to electrophysiological signals. Examples of this includes 
dual-humped optical action potential morphology due to activation from multiple layers [70] or 
changes in the optical action potential upstroke based on sub-surface electrical wave propagation 
direction [71]. Therefore, to enable better interpretation of optical mapping measurements, models 
that simulate the synthesis of the optical mapping signal have been developed. Image-based 
models of ventricular tissue have been created and used to simulate optical mapping [72-76]. 
1.3.3 Remaining Challenges in Left Atrial Imaging and Modeling 
Several challenges remain in the detailed imaging of the human left atrium, particularly in 
terms of imaging resolution. The average thickness of the human left atrial wall is 3 mm, with a 
range from 1.5 mm to 6.5 mm. [77] Recent studies have observed differences in electrical 
activation patterns between the endocardial and epicardial atrial wall, sparking interest in the 
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electrical propagation that may occur transmurally over the depth of the atrial wall. [14, 78] The 
left atrial wall is composed of complex layers of myofibers that may be oriented at nearly 
orthogonal directions at different depths or have abrupt changes in orientation. [58, 79] Fibrosis 
can have different types of distributions throughout the wall, being interstitial, patchy, or diffuse. 
While it is has been observed that fibrosis provides an arrhythmogenic substrate, the relative effect 
of the specific 3D distribution of fibrosis throughout the depth of the wall remains to be 
determined. [50] Due to the thinness of the left atrium, current cardiac imaging modalities remain 
limited in their ability to resolve finer features across the heart wall, including myofiber orientation 
over depth in thin regions, specific distributions of fibrosis, and smaller fatty infiltrations. In light 
of these challenges, optical coherence tomography (OCT) may be a useful adjunctive imaging 
modality that can offer valuable information where other imaging modalities face difficulties. OCT 
has micrometer resolution, is non-destructive, and can be incorporated into imaging catheters for 
in vivo imaging. Therefore, OCT may be highly applicable for providing imaging guidance for 
ablation, enabling better understanding of the left atrial substrate, and informing realistic 
electrophysiological models. 
1.4 Optical Coherence Tomography 
Since its origins in the early 1990s [80], optical coherence tomography (OCT) has become 
a well-established imaging modality for biomedical and clinical applications. Based on low 
coherence interferometry, OCT images the depth profile of a tissue sample by measuring the 
interference between light backscattered from the sample and light reflected from a reference 
mirror. OCT can non-destructively image the three-dimensional microstructure of biological 
tissues with an imaging resolution ranging from 1 to 15 μm, penetration depths of 2 to 3 mm [81], 
and video rate imaging speeds [82]. OCT can also provide functional data, such as the 
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measurement of birefringence, a useful indicator of tissue organization, using polarization 
sensitive (PS) OCT [83]. OCT has been applied to ophthalmology [84], intravascular imaging [85], 
dermatology [86], gynecology [87], and other clinical and research fields. 
1.4.1 Time Domain Optical Coherence Tomography 
The basic mechanism of OCT is based on the Michelson interferometer. The first type of 
OCT system developed was Time Domain (TD) OCT, and a simplified schematic of a TD-OCT 
setup is provided in Figure 1.1. Light from a broadband, low coherence light source is directed 
towards a beam splitter, which directs light towards the sample arm containing the sample to be 
imaged and the reference arm containing a mirror. Light incident upon the sample is backscattered 
due to discrete reflecting particles within the sample as well as changes in refractive index. Light 
from both arms are reflected back towards the beam splitter, where the beams recombine and are 
then collected by the detector. For TD-OCT, the detector is a single-channel photoreceiver. 
 
Figure 1.1. Time domain OCT system schematic. In this example, the depth of the sample ranges from z0 to 
zmax. The reference mirror is axially scanned over an equivalent distance to capture the reflectivity profile of 
the tissue sample.  
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 The interference pattern of light from the reference and sample arms can only be resolved 
when the optical path length difference between the two beams, determined by the position of the 
mirror and the depth in the tissue from which the light was backscattered, is less than the coherence 
length of the light source. For a given position of the reference mirror, an interference fringe burst 
is generated corresponding to a localized depth within the tissue. For a fixed x-y position on the 
sample, the reference mirror can be translated with a piezoelectric stage to generate an 
interferogram containing a fringe burst pattern corresponding to the interference from multiple 
depths. This interference burst pattern can then be demodulated to generate an intensity depth 
profile of the sample, called an A-scan. This procedure is represented in Figure 1.2, which shows 
the detected interferogram and corresponding A-line, post-demodulation, corresponding to four 
discrete reflectors equally spaced throughout the depth of an imaged sample. 
 
Figure 1.2. Simple OCT interferogram (blue) and A-line after demodulation (red). The corresponding, true 
reflectivity of the sample over depth is given below. 
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Galvo mirrors are used to scan the beam over the sample in lateral dimensions. The 
acquisition of multiple A-lines can be composed into a two-dimensional image, called B-scans. 
Scanning in both x and y lateral dimensions enables the generation of three-dimensional image 
volumes, as shown in Figure 1.3. 
 
Figure 1.3. Examples of acquired OCT data. The orange line corresponds to A-line location within the B-scan, while 
the blue box corresponds to the B-scan location within the 3D image volume. 
1.4.2 Fourier Domain Optical Coherence Tomography 
Developed after the creation of TD-OCT, Fourier Domain (FD) OCT captures the 
interference pattern in the spectral domain instead of the time domain. FD-OCT has been 
demonstrated theoretically and experimentally to have superior sensitivity than TD-OCT, enabling 
higher speed imaging applications [88-90]. FD-OCT is divided into two sub-categories: spectral 
domain (SD) OCT, in which a spectrometer and array detector are used for detection, and swept-
source (SS) OCT, or optical frequency domain imaging (OFDI), in which a wavelength-swept 
light source is used for illumination and a single or small number of photoreceivers detect the 





Figure 1.4 Spectral domain and swept-source OCT system schematics. 
In FD-OCT, the reference arm remains stationary and is fixed at a distance equivalent to 
the approximate location of the sample. The full depth profile of the tissue sample at a given x-y 
location is encoded within the detected interferogram, which is collected in the spectral domain. 
The spectral interferogram collected by the detector must be pre-processed and inverse Fourier 
transformed to obtain the intensity depth profile of the sample. The basic signal processing steps 
for this procedure are as follows. First, the DC component of the spectral interferogram must be 
removed, which occurs primarily due to the reference mirror. The DC component can be removed 
by detecting a signal with only the reference mirror, and no sample present in the sample arm, and 
using the resulting signal as a template for the DC component and subtracting it from subsequently 
detected signals. Second, the spectrum must be converted from wavelength domain to 
wavenumber domain. Finally, the spectral interferogram must be Fourier transformed to construct 
the A-line. 
1.4.3 Optical Coherence Tomography Parameters 
The axial resolution of both TD- and FD-OCT systems, 𝛿𝑧, is governed by the light 
source’s central wavelength 𝜆0 and full-width at half-maximum (FWHM) bandwidth ∆𝜆. 
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Equivalently, the axial resolution is proportional to the coherence length of the light source, which 
is the FWHM of its coherence function. Assuming a Gaussian spectrum, the equation for axial 










The lateral resolution of an OCT system, 𝛿𝑥, is defined as the FWHM of the point spread 
function of the sample arm beam at the focal plane. It is determined by the central wavelength of 







 The axial field of view, 𝐹𝑂𝑉𝑎𝑥𝑖𝑎𝑙, or depth of focus of an OCT system is defined as the 
FWHM of the confocal axial response function, which is dependent on the center wavelength of 










Lateral resolution and axial field of view are inversely proportional, and there is a tradeoff 
between the two parameters in OCT system design. The lateral field of view, 𝐹𝑂𝑉𝑙𝑎𝑡𝑒𝑟𝑎𝑙 of an 
OCT system is dependent on its individual lateral scanning mechanism. However, assuming the 
scanning mechanism has a maximum scan angle of θ𝑚𝑎𝑥 through the input aperture of the 
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objective lens and that the objective lens has a focal length, 𝑓, the 𝐹𝑂𝑉𝑙𝑎𝑡𝑒𝑟𝑎𝑙 can be given by the 
following. [91] 
 
𝐹𝑂𝑉𝑙𝑎𝑡𝑒𝑟𝑎𝑙 = 2𝑓θ𝑚𝑎𝑥 (1.4) 
 
1.5 Cardiac Applications of Optical Coherence Tomography 
Due to its high resolution, fast imaging speeds and non-destructive imaging capabilities, 
the use of OCT to image cardiac microstructure has increased over the past two decades. Currently, 
the primary applications have been the imaging of heart tissue structure in small animal models, 
especially the imaging of myofiber organization, and the monitoring of radiofrequency ablation 
lesion formation using OCT-integrated catheter designs. The imaging of cardiac tissue structure in 
large animal models, and in particular, OCT imaging of the human heart, has also been of recent 
interest. 
1.5.1 OCT Imaging of Cardiac Structure in Animal Models 
OCT has been used to image myofiber orientation, small animal heart morphology, and the 
organization of the cardiac conduction system. OCT imaging and extraction of myofiber 
orientation has been demonstrated using both intensity-based [92-98]  and polarization sensitive 
methods [83, 99-103] in both small and large animal hearts. In some cases, optical clearing [94, 
96] or serial sectioning [97] have been employed to improve imaging depth. Myofiber 
disorganization and variability identified through OCT have been correlated to regions of 
infarction and cardiomyopathy in mouse or rat ventricles [83, 102, 103]. Through the use of 
stitching algorithms to combine multiple OCT image volumes encompassing the whole heart, 
morphological parameters such as heart size, wall thickness, and mass have also been measured 
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for diseased and normal small animal hearts [102, 104].  Structural features of the cardiac 
conduction system, including the Purkinje network [105], the atrioventricular node [93, 106, 107], 
and sinoatrial node [107] have been investigated using OCT in the rabbit and canine heart. OCT 
measurements of myofiber orientation in the sinoatrial node, atrioventricular node, and right 
ventricular free wall have been correlated to fluorescent measurements of electrical conduction, 
enabling better understanding of the influence of myofiber orientation on cardiac function [93, 
106, 107]. Biomechanical characterization of cardiac tissue has also been carried out using shear 
wave imaging OCT [108]. 
1.5.2 OCT Imaging for Radiofrequency Ablation Guidance 
With its high imaging speed and resolution, OCT has been proposed as a real-time imaging 
guidance tool for ablation procedures for atrial fibrillation. OCT-integrated catheters have been 
developed [109-112] and imaging of myocardial features have been demonstrated in vivo in swine 
hearts [113, 114]. OCT is able to identify tissue contact between the probe and the cardiac wall 
[110, 113, 114], as myocardial features become more apparent with the displacement of blood that 
occurs at probe contact. The location and development of ablation lesions can be tracked with OCT 
by the appearance of the birefringence artifact band, which is a dark band in the myocardium that 
disappears within regions of ablation lesions [109, 110, 115]. However, because the birefringent 
artifact may fluctuate in an in vivo setting [114], PS-OCT approaches to identifying the ablation 
lesion have been proposed as a more sensitive indicator [111, 112, 116]. OCT imaging during 
ablation may also be able to provide information of tissue structural changes indicative of 
complications occurring during energy delivery, such as the formation of tears within the ablated 




1.5.3 OCT Imaging of the Human Heart 
There have been a few studies of OCT imaging in the human heart. In 2009, general 
features such as myofiber organization from small regions from the human right atrium, left and 
right ventricles, atrioventricular node, and sinoatrial node were presented. [117] In 2016, different 
tissue types within human left atrial tissue, including dense collagen, loose collagen, fibrotic 
myocardium, adipose tissue, and normal myocardium, were imaged and analyzed using an 
automatic classification scheme. [118] An ultra-high resolution OCT system has been developed 
and shown to image detailed tissue features such elastic fibers, collagen fiber bundles, adipose 
tissue, myofibers, and chordae tendineae in the human ventricular septum. [119] A high resolution 
cross-polarization OCT system also showed distinguishing features between endocardial scar, 
thickened endocardium, fibrosis, and ablation lesions in the right ventricular septum. [116] 
These imaging studies focused on small regions of the human heart chambers, without 
providing a comprehensive study of the distribution of different tissue types throughout the 
chamber or analyzing the tissue features identified with OCT in relation to cardiac anatomy. 
Because the dynamics of atrial fibrillation are closely tied to atrial anatomy and spatial distribution 
of structural features, it is necessary to identify tissue features in the context of the whole atrial 
anatomy. More comprehensive imaging is necessary to determine the full utility of OCT in 
improving our understanding of the structural substrate of atrial fibrillation. Additionally, the use 
of OCT to inform structurally realistic cardiac models for simulating electrophysiological 





There exists a need to better define the structural substrate of atrial fibrillation, including 
depth-resolved information on myofiber orientation, fibrosis, and adipose tissue. OCT imaging 
can provide valuable, high-resolution information on tissue microstructure, and advances have 
already been made in applying OCT to cardiac imaging and atrial fibrillation ablation guidance. 
However, comprehensive imaging of the human atria with OCT and the integration of OCT 
imaging data in electrophysiological modeling, like those that exist for MRI and CT, remain to be 
established. This information could provide further guidance on the application of OCT to the 
treatment of atrial fibrillation. Therefore, the objectives of this study are as follows: (1) to 
comprehensively image the human left atrium with OCT, providing a detailed overview of the 
tissue and image features that can be expected in OCT imaging of the human left atrium, and 
provide these features within the context of the whole left atrial anatomy, and (2) to develop a 
modeling workflow to integrate OCT imaging data of atrial tissue into tissue-specific, cardiac 
models for electrophysiological and optical mapping simulation. The thesis is organized as 
follows. Chapter 2 provides an overview of the OCT image features of the human left atrium and 
pulmonary veins and the distribution of imaged tissue features throughout the chamber. The OCT 
imaging data of the human left atrium will also be discussed in the context of a whole human heart 
OCT imaging atlas. Chapter 3 describes the modeling workflow for integrating structural features 
extracted from OCT into models for electrophysiological and optical mapping simulation. Chapter 
4 provides several applications of the modeling workflow to OCT-derived models of cardiac tissue 
incorporating myofiber orientation, ablation lesions, and different tissue types. Chapter 5 will 




Chapter 2 Comprehensive Characterization of 
the Human Left Atrium with Optical 
Coherence Tomography 
2.1 Introduction 
Detailed imaging of tissue structure in the human left atrium is a growing area of research for 
improving the understanding and treatment of atrial fibrillation. With the acknowledgement that 
complex interactions with tissue microstructure across the atrial wall may maintain arrhythmia 
mechanisms [14, 78, 120], there have been significant efforts in improving the resolution of 
imaging in the human atria as described previously in Chapter 1.3. Through these imaging studies, 
as well as from information gathered from histological studies, a general understanding of left 
atrial features potentially contributing to atrial fibrillation mechanisms has been developed, with 
particular attention paid to the influence of myofiber orientation and fibrosis. An overview of tissue 
features of interest and their relevance as potential structural substrates of atrial fibrillation is 
briefly provided below to establish the current body of knowledge before exploring OCT imaging 
of the human left atrium. 
2.1.1 Myofiber Orientation in the Left Atrium 
Myofiber orientation in the human left atrium has been described as being composed of 
one to three layers, [79] with the myofiber layers blending into one another or, in contrast, angled 
nearly orthogonally to one another with abrupt changes in orientation over depth. [121] Myofiber 
orientation within the left atrium has been noted to be heterogeneous, with dispersion of transmural 
fiber orientation varying over different regions of the left atrium. The inferior and anterior sides of 
the left atrium and areas near the pulmonary veins were reported to typically have higher 
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transmural dispersion, while the lateral wall below the left pulmonary veins had lower dispersion. 
[58] Additionally, several studies have commented that a generalized pattern of myofiber 
orientation can be observed across the left atria of different hearts, but local variations and 
exceptions to typical patterns were frequently noted. [58, 121, 122] Regions of complex myofiber 
orientation and abrupt changes in fiber angle have been associated with arrhythmia dynamics, such 
as anchoring of high-frequency drivers [15] and activation time dispersion. [53] Remodeling of 
transmural fiber orientation associated with atrial fibrillation, as observed in goat atria, has been 
proposed to contribute to dissociation of endocardial and epicardial electrical activity. [16] On the 
contrary, differences in left atrial myofiber orientation of atrial fibrillation patients compared to 
healthy patients were not found in a small sample size of human left atria as imaged by DT-MRI. 
[58] Remaining questions on the influence of myofiber orientation on atrial fibrillation, especially 
as part of a transmural three-dimensional substrate, and the variability and potential remodeling 
among different individuals suggests a need for high-resolution, personalized imaging to further 
probe the effect of myofiber organization on arrhythmia. 
2.1.2 Fibrosis in the Left Atrium 
The extent of fibrosis in the atria, as imaged with DE-MRI, has been shown to be a 
significant indicator of ablation outcomes. [42] However, further research is needed to define the 
specific relationship between fibrosis and atrial fibrillation, and particularly the influence of 
different densities of fibrosis on arrhythmia dynamics. Fibrosis can exist in categories based on 
their distribution, such as interstitial, diffuse, compact, and patchy fibrosis, as shown in Figure 2.1, 




Figure 2.1. Trichrome histology slides of different distributions of fibrosis. Collagen is indicated by blue, and 
myocardium is indicated by red. A, Interstitial fibrosis. B, Diffuse fibrosis. C, Compact fibrosis. D, Patchy fibrosis. 
 Currently, the influence of compact and diffuse fibrosis has not been demonstrated to 
significantly contribute to atrial fibrillation dynamics. However, several histological studies have 
identified the influence of patchy and interstitial fibrosis on atrial fibrillation propagation. Patchy 
fibrosis has been reported through optical mapping experiments and computer simulation to be 
involved in arrhythmogenic behavior by anchoring reentrant waves and causing conduction delays 
and fractionation. [123] Interstitial fibrosis has been reported to be more abundant in goat models 
of long term or chronic atrial fibrillation, and have been proposed to support dissociation between 
epicardial and endocardial electrical patterns and cause anisotropic slowing of conduction. [124, 
125] Gadolinium-enhanced (GE) MRI has imaged interstitial fibrosis in the human right atria, 
which were determined to cause transmural activation delays and anchor reentrant drivers, [14] 
while correlation of LGE-MRI imaging to optical mapping experiments and simulations has shown 
that atrial fibrillation drivers clustered around the borders of fibrotic atrial regions. [17] These 
studies support that patient-specific and three dimensional distributions of fibrosis have a 
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significant influence on arrhythmia dynamics. However, detailed imaging of fibrosis distributions 
across the left atrial wall has not yet been demonstrated. 
2.1.3 Other Structural Substrates of Atrial Fibrillation 
Other features of interest relevant to atrial fibrillation include adipose tissue, as well as 
anatomical structures such as the pulmonary veins and the atrial septum. Increased epicardial 
adipose as well as interatrial fat have been associated with atrial fibrillation, [65] and increased 
epicardial adipose tissue has been found to be a predictor of radiofrequency ablation recurrence. 
[126]  Epicardial fat may infiltrate into the myocardium and has been theorized to influence 
conduction, [18] but the effect of intra-myocardial adipose deposits within the human atria on 
electrophysiological patterns have not yet been well-studied.  
The pulmonary veins have become highly relevant to atrial fibrillation after the discovery 
that ectopic beats originating from the myocardial sleeves of the pulmonary veins are often the 
initial triggers for atrial fibrillation, particularly for paroxysmal atrial fibrillation. [24] As 
identified from histology, the pulmonary veins are internally composed of venous media and an 
external fibro-fatty adventitia. The transition from left atrial tissues to the pulmonary veins is a 
gradual one, and myocardial extensions from the left atrium into the pulmonary veins can extend 
as far as 25 mm into the vein. [127, 128] A thin fibrofatty or loosely fibrous layer has been observed 
between the venous media and the myocardial sleeves. [129, 130] A representative histology slide 




Figure 2.2. Pulmonary vein structure. 
Reentry is often cited to anchor around the pulmonary veins, [131] and from a structural 
viewpoint, may be influenced by the heterogeneous myofiber orientation and fibrosis that can be 
commonly found around and inside the pulmonary veins. Histological studies have shown that the 
myocardial sleeves can have complex myofiber arrangement with crossing and mesh-like patterns 
[127, 130]. Studies in canines have shown regions of myofiber complexity correlated to electrical 
conduction disturbances, [132, 133] while arrhythmogenic high-frequency potentials have been 
associated with thickened PV walls [69]. AF patients have also been reported to have higher 
degrees of discontinuity, hypertrophy, and fibrosis within their PV myocardial sleeves [128]. 
The interatrial septum in normal developed hearts contains the remnants of the valve of the 
foramen ovale, which was originally an open channel in which blood could flow in the developing 
heart. During radiofrequency ablation, the left atrium is accessed by puncturing the thinnest part 
of the septum, the fossa ovalis, which is typically composed of endocardium on both sides with 
myocardium in between. [134] From the left atrial side, the septum is difficult to identify from the 
other walls of the left atrium other than by the appearance of a small crescent wedge or through 
transillumination to identify the thin region of the fossa ovalis. [121] The interatrial septum has 
been noted as one of the most common locations where non-pulmonary vein triggers of atrial 
fibrillation can be found. [38] 
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2.1.4 OCT Imaging of the Human Left Atrium and Objective 
OCT imaging guidance for radiofrequency ablation of atrial fibrillation has been under 
investigation over the past few years, with OCT-integrated catheters for lesion monitoring having 
been developed and tested in vivo in swine hears. [112-114] However, while there have been a few 
studies focused on imaging specific features within human hearts, such as different tissue types, 
[118] lesions, [112] and features of the conduction system, [117] there is a lack of comprehensive 
OCT imaging data covering the whole human left atrium. Understanding the spatial distribution 
of tissue features as imaged by OCT in the context of the whole left atrial anatomy can provide a 
better understanding of the applicability of OCT to mapping the structural substrate of atrial 
fibrillation. Furthermore, OCT imaging of the human left atrium contributes to a whole human 
heart OCT imaging atlas, such as those that currently exist for intravascular OCT [135] and retinal 
OCT imaging [136]. Such an atlas, more generally speaking, can guide future cardiac applications 
of OCT. Therefore, the objective of this chapter is to provide a detailed overview of OCT imaging 
features in the human left atrium, assessing the capability of OCT to image important structural 
features, as well as provide insight on an overall cardiac OCT imaging atlas. 
2.2 Methods 
2.2.1 Tissue Acquisition 
Diseased human hearts (n=21) were acquired under an approved protocol from the National 
Disease Research Interchange (NDRI). The inclusion criteria for the protocol was based on the 
following diagnoses: end stage heart failure, cardiomyopathy, coronary heart disease, amyloid, 
atrial fibrillation, and myocardial infarction. NDRI received consent for all donors. All specimens 
were de-identified and considered not human subjects research, according to the Columbia 
University Institutional Review Board Under 45 CFR 46. Donor characteristics are provided in 
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Table 2.1. The average age was 60 years, with a range of 43 to 77 years. There were 12 female 
and 9 male donors. Two donors had a history of atrial fibrillation, 7 had congestive heart failure, 
3 had myocardial infarction, and 3 had valvular heart disease. Recovery of hearts was completed 
within 24 hours after death, and the hearts were delivered to the lab while submerged in an ice-
cold phosphate-buffered saline bath. From the 21 hearts, 11 left superior pulmonary veins, 9 right 
superior pulmonary veins, 11 left inferior pulmonary veins, and 8 right inferior pulmonary veins 
were imaged. Nine pulmonary veins were imaged with surrounding ablation lesions, created using 
the commercial RFA system, Stockert 70 (Biosense Webster, Diamond Bar, CA), to evaluate OCT 
imaging of lesions within human atrial tissue.  
Table 2.1 Heart donor characteristics. 
Heart # Age Sex Cardiovascular Disease History 
1 54 M HTN 
2 43 M HTN, HLD, CHF 
3 58 F HTN 
4 67 F HTN, HLD 
5 52 M MI 
6 62 M HTN, HLD, CAD 
7 62 M CHF, VHD, AF, VT, PVD 
8 54 F PVD 
9 77 F CAD, HTN, CHF, AF, PVD 
10 70 F CHF, HTN 
11 46 F HTN, CAD, MI 
12 67 M MI, HTN, HLD 
13 59 F HTN 
14 67 M CHF, VHD, HLD 
15 58 M CAD, CHF, HTN, HLD 
16 68 M HTN, CAD, HLD 
17 62 F HLD, CAD 
18 56 M VHD, HCM, HTN 
19 55 M CHF 
20 58 F VHD 
21 69 M HTN, CAD, HLD 
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AF: atrial fibrillation; CAD: coronary artery disease; CHF; congestive heart failure; HCM: hypertrophic 
cardiomyopathy; HLD: hyperlipidemia; HTN: hypertension; MI: myocardial infarction; PVD: peripheral vascular 
disease; VHD: valvular heart disease; VT: ventricular tachycardia 
2.2.2 Dissection Protocol 
Upon arrival to the lab, the left atrium and pulmonary veins were isolated from the rest of the heart. 
Afterwards, the left atrium and pulmonary veins were dissected to flatten the tissues for imaging 
with OCT. Excluding the initial 6 hearts, which were used for establishing the optimal dissection 
procedure or for imaging smaller regions of interest, the left atria were dissected with the following 
procedure to enable flattening of the tissues with the least amount of cuts and to facilitate easy 
identification of anatomical features after dissection. An example of the dissection procedure is 
depicted in Fig 2.3. The left atrium was halved, separating the left pulmonary veins from the right 
pulmonary veins as shown by the dotted black line in the left-most panel of Fig 2.3. Afterwards a 
longitudinal cut was made along the side of each vein and into the left atrium, as represented by 
the dotted red line in Fig 2.3. This dissection opened up the vein while keeping the venoatrial 
junction intact. The flattened tissues were pinned to a corkboard for imaging. The tissues were 
submerged in a 10:1 phosphate buffered saline solution to prevent the tissue from drying when 
imaging over larger regions. Due to the left atrial appendage’s highly trabeculated surface and the 
limitations of OCT’s imaging depth, the left atrial appendage was not imaged. Three hearts 




Fig 2.3 Diagram of the dissection procedure and orientation of OCT image volume relative to the tissue. A 
representative example of the LIPV flattened for imaging is shown. RSPV = right superior pulmonary vein, 
RIPV = right inferior pulmonary vein, LSPV = left superior pulmonary vein, LIPV = left inferior pulmonary 
vein. 
2.2.3 Imaging Protocol 
All tissues were imaged fresh with no prior fixation to evaluate the applicability of imaged tissue 
features to in vivo imaging. The tissues were imaged with the TELESTO I (Thorlabs GmbH, 
Dachau, Germany) spectral-domain OCT system, which has an axial resolution of 6.5 μm, lateral 
resolution of 15 μm, and imaging depth of 2.51 mm in air. The system uses a matched pair 
broadband superluminescent diode light source, with a center wavelength of 1325 nm and a 
bandwidth of over 150 nm. It uses a linear InGaAs array-based spectrometer. Its maximum axial 
line rate is 91 kHz, and imaging was carried out at 28 kHz.  The OCT-IMM3 immersion-style 
sample z-Spacer (Thorlabs GmbH, Dachau, Germany) was used to image the tissues while 
submerged in a phosphate buffered saline solution, as shown in Figure 2.4.  Overlapping, 3D image 
volumes were obtained to cover large regions of tissue. The image volumes were captured with 
pixel sizes ranging from 5.0 to 6.3 μm in the lateral dimension and 4.9 μm in the axial dimension, 
in air. Sizes of the image volumes ranged from 3.0 to 5.0 mm in the lateral dimension and 2.51 




Figure 2.4. OCT imaging of human left atrial tissue with the OCT-IMM3 immersion-style sample z-Spacer. 
2.2.4 Histology 
After imaging, the tissues of the imaged areas were cut into blocks and placed in 10% formalin for 
at least 24 hours fixation before being transferred to 20% ethanol. The blocks had maximum x-y 
dimensions of 40 mm by 30 mm, and 5 μm thick levels were obtained from each block with a 
maximum of 3 mm between each level. The levels were obtained in the same orientation as the 
OCT B-scans, except for select regions where levels in the en face view were also obtained to 
enable comparisons of fiber orientation between OCT and histology. The tissues were stained with 
Masson’s Trichrome, and a Leica SCN400 (Leica Microsystems, Wetzlar, Germany) slide scanner 
with x40 magnification was used to digitize the histology slides. Afterwards, different tissue types 
were identified from the slides by a cardiovascular pathologist blinded to the OCT images. 
Histology slides were matched to OCT images acquired from the same location that the histology 
block had been excised from. Locations of the histology blocks and OCT volumes were determined 
based on camera images taken during the cutting of the histology blocks and white light images 
acquired by the TELESTO I system that depicted the field of view within each OCT volume. 
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2.2.5 Image Processing 
2.2.5.1 Image Stitching 
Overlapping image volumes were registered and stitched into composite image volumes to better 
visualize the tissue features. First, the image volumes were manually registered in the en face plane 
(x and y-dimensions) based on matching tissue surface features in the white light images and 
known lateral translations between each volume during imaging. Custom MATLAB software was 
used to manually align overlapping white light images and determine the lateral offsets between 
each consecutive, overlapping pair of image volumes. 
The tissue surfaces also need to be aligned in the axial dimension. If the tissues were 
imaged without the z-Spacer, the tissue surfaces were manually aligned from a sampling of 
overlapping B-scans from the image volumes to be stitched. If the tissues were imaged with the z-
Spacer, however, the contact glass of the z-Spacer deformed the tissue surface, making alignment 
of the tissue surfaces difficult. Therefore, to ensure the tissue surfaces were axially aligned in 
stitched image volumes where the z-Spacer was used, the tissue surfaces of each volume were 
flattened to a uniform depth by surface detection and subsequent shifting of the image pixels. 
Surface detection was carried out on individual B-scans in all image volumes. First, the B-scan 
was median filtered with a 3 x 3 kernel to smooth speckle noise. Afterwards, the filtered B-scan 
was thresholded to separate the image background from the tissue regions. The threshold was 
empirically determined from a subset of B-scans, and the same threshold was applied to all image 
volumes. The tissue surface and the contact glass from the z-Spacer are both highly reflective, 
leading the contact glass of the z-Spacer to be segmented along with the tissue region and 
interfering with surface detection. Because the contact glass can be seen as a thin, primarily 
horizontal straight line within the B-scan, the z-Spacer contact glass signal was removed from the 
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thresholded image by morphological opening using a 15 x 1 rectangular structuring element. With 
the contact glass signal removed, the tissue surface remains in the segmented image. Therefore, 
the pixel location of the maximum intensity in each column was taken as the axial position of the 
tissue surface. The detected tissue surface was smoothed by a 1D median filter with a kernel size 
of 25. After the location of the tissue surface in a B-scan was determined, the pixels of each column 
were shifted up the number of pixels necessary to place the tissue surface at a uniform depth 
throughout the image. 
After the lateral offsets between consecutive, overlapping pairs of image volumes were 
determined and the tissue surfaces of all image volumes were aligned, the image volumes could 
be stitched together to form the composite image volume. The placement of each image volume 
in the stitched domain was determined by solving a linear system of equations formed from the 
known lateral offsets. The coordinates of the origin for an image volume i can be denoted as (xi, 
yi, zi). The offsets in the x, y, and z dimensions between the origins of consecutive, overlapping 
image volumes i and i+1 can be denoted as Dxi(i+1), Dyi(i+1), and Dzi(i+1) respectively. Given n 
individual image volumes and selecting a minimum xi, yi, and zi, 3(n-1) unknowns needed to be 
determined to identify each volume’s location in the stitched domain. A set of 3(n-1) equations of 
the forms xi – xi+1 = Dxi(i+1), yi – yi+1 = Dyi(i+1), and zi – zi+1 = Dzi(i+1) could be created from the 
known lateral offsets, and the system of equations was solved in matrix form. Once the location 
of each image volume in the stitched domain was determined, stitching was carried out using 
multiband blending methods as have been described in prior work [137] to smooth the transitions 
between image volumes. Gain compensation was applied as necessary to some stitched volumes 
based on image quality. For larger stitched volumes, the stitched image volumes were 
downsampled by three to decrease computational burden and improve ease of visualization. For 
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visualization, a uniform contrast adjustment was applied over the entirety of each B-scan or en 
face image until the image features were clear. Representive resulting stitched image volumes are 
provided in Figure 2.5. 
 
Figure 2.5. 3D reconstructions of stitched image volumes from regions taken from A, Heart 9# and B, Heart 
#13. The left column shows the endocardial surface of the tissue, while the right column shows views at 
sub-endocardial depths, demonstrating sub-surface structural detail.  
2.2.5.2 Endocardial Thickness Quantification 
Because the visibility of myocardial features such as myofiber orientation and collagen fibers in 
OCT is sensitive to the thickness of overlying connective tissue, measurements of endocardial 
thickness were acquired to identify the maximum endocardial thickness under which myocardial 
features could be seen within this OCT system’s imaging depth. Such measurements also enabled 
comparison between histology and OCT measurements of endocardial thickness. Measurements 
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were obtained from the venoatrial junctions, where fiber orientation and collagen fibers could be 
commonly observed in OCT. Because variations of endocardial thickness occur around a single 
venoatrial junction, measurements of endocardial thickness were obtained from three points per 
pulmonary vein. These points were taken from regions where fibrosis and fiber orientation were 
visible at the venoatrial junction as determined from the en face OCT images. Three measurements 
were measured manually from OCT B-scans, calculated using a refractive index of 1.4 for atrial 
tissue, with another three measurements acquired from corresponding histology images for 
comparison. 
2.2.5.3 Adipose Tissue Quantification 
Adipose was manually segmented with IMOD [138]  within each en face image where adipose 
was present. The presence of adipose was determined by a brightly spotted or “honeycomb” 
pattern, typically with a background of decreased intensity than surrounding myocardium. Adipose 
thickness was determined by summing the segmented voxels in the axial direction and converting 
the summed values to real dimensions based on the axial resolution. Overall adipose tissue volume 
was computed for each left atrium in which all major regions of the left atrium were imaged with 
OCT. Additionally, because the interatrial septum in particular was found to contain significant 
adipose deposits, the adipose tissue volume in only the septum region was computed. 
2.2.5.4 Myofiber and Texture Quantification 
The distribution of collagen fibers in the myocardium varied from region to region, particularly in 
the myocardial sleeves of the pulmonary veins. To provide a quantitative measure of these 
differences, texture analysis was carried out in the myocardial regions of representative pulmonary 
veins. A 4.0 x 8.6 x 0.1 mm region of interest was extracted from the myocardial region of the 
pulmonary veins. Within each B-scan in the 3D region of interest, the local range, standard 
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deviation, and entropy were computed with a 3 x 3 kernel, and these values were averaged over 
the entire region of interest. Fiber orientation angles were also extracted from each en face image 
over depth in the region of interest, using a previously described gradient-based method [95]. The 
circular standard deviation was calculated from all of the extracted angles in the 3D region of 
interest to quantify variation in fiber orientation. Fiber orientation angle extracted using the 
gradient-based method was also plotted against depth to quantify transmural trends. For overall 
fiber orientation trends over large regions, fiber orientation was demarcated manually based on 
visual striations observed within the en face OCT images at a single representative depth. 
2.2.5.5 Registration of OCT Maps to Atrial Anatomy 
Registration of white light and en face OCT images to a 3D left atrium model was carried out to 
facilitate interpretation of image features of dissected tissue with respect to overall left atrial 
anatomy. Registration was carried out in the open-source, 3D computer graphics software Blender. 
The registration procedure is depicted in Figure 2.6. A 3D left atrium model from the Continuity 
6 online database, developed by the Cardiac Mechanics Research Group of the University of 
California San Diego, was used as a reference left atrium model. [139] 
White light images were mapped to the model first because anatomical landmarks used for 
registration could be more easily identified in the white light images as opposed to the OCT 
images. Knowledge of the location of cuts made during dissection, as well as anatomical 
landmarks, such as the pulmonary veins and left atrial appendage, facilitated the wrapping of the 
white light images of the dissected tissues back into a 3D form. The mapping was carried out using 
Blender’s UV mapping interface, where white light images were manually registered to the 
appropriate faces of the mesh. To provide a smooth visualization, histogram equalization and 
illumination correction were carried out for the white light images of each heart. Illumination 
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correction was accomplished by converting the white light images from RGB to the HSV domain. 
Within the HSV domain, the average illumination, calculated as the average of the V channel, was 
computed over the entire white light image. Regional illumination was then computed by Gaussian 
filtering the V channel with a 200 x 200 kernel and a 100 pixel standard deviation. The regional 
illumination was replaced by the uniform, average illumination by subtracting the Gaussian filtered 
V channel from the original V channel and adding the overall average of the original V channel. 
After the white light images were registered to the model, OCT en face images could be 
manually registered to the white light images based on anatomical landmarks and the shape of the 
imaged region, and then subsequently registered to the model with an identical procedure. The en 
face OCT images simply replace the texture data of the model in lieu of the white light images. 
Similarly, any parameters derived from the OCT images, such as adipose tissue thickness and fiber 
orientation, could be registered to the 3D model with the same approach.  
 
Figure 2.6 Overview of registration of OCT image maps to the 3D model. 
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2.2.5.6 Statistical Analysis and Whole Human Heart Cardiac Atlas 
The left atrial imaging data acquired within this study was also combined with OCT imaging of 
other chambers, including the right atria and ventricles. The combined dataset contains OCT 
images obtained from 50 human hearts, and this full dataset comprises the whole human cardiac 
OCT imaging atlas. The same OCT imaging system as previously described was used to obtain 
the data from the other chambers. For this study, about two to three image volumes were selected 
per chamber for each heart. Histology was obtained as previously described and registration of 
OCT and histology was performed by two investigators, blind to the classification results, under 
the guidance of a pathologist. Overall, 573 pairs of OCT-histology matches were made in the full 
cardiac atlas. 
Based on the OCT-histology pairings, features from regions with known tissue types were 
extracted. In each OCT image, key features including attenuation coefficient, contrast, correlation, 
energy, homogeneity, standard deviation, skewness, and kurtosis were calculated. Attenuation 
coefficients, µt, was measured based on a previously described model. [140] Attenuation 
coefficient characterizes how easily a material or medium can be penetrated by a beam of light. 
Contrast, correlation, energy, and homogeneity were extracted from gray level co-occurrence 
matrices (GLCM). These features quantify texture patterns within OCT images, such as local 
variation, joint pixel distribution, and uniformity. In addition, statistics of pixel distribution; such 
as standard deviation, skewness, and kurtosis; were included. The tissue types included in this 
study were collagen, normal myocardium, adipose, and fibrotic myocardium. The feature 
extraction was performed in a region of interest from each B-scan with a size of 320 by 160 µm. 
Statistical differences between groups were examined using ANOVA analysis, in Prism 8, 





In general, the endocardium in OCT was characterized by a highly backscattering, homogeneous 
layer on the tissue surface. When the entire thickness of the endocardium was within the imaging 
penetration depth, a sharp transition from the highly backscattering upper layer to a lower intensity 
region underneath could be observed, indicating a transition to myocardial tissue as shown in 
Figure 2.7A. This distinct boundary between the upper layer of connective tissue and the 
myocardium underneath can also be applied to myocardium underneath venous media. Because 
the venous media and endocardium blend at the venoatrial junction, connective tissues overlying 
myocardium will hereafter always be referred to as endocardium for simplicity, unless it is 
necessary to distinctly specify the presence of venous media. 
The boundary between the endocardial and myocardial layers enabled identification of 
endocardial thickness. However, if the endocardium was thicker than the penetration depth, a 
gradual fall-off of intensity in the upper layer was observed instead, as shown in Figure 2.7B. 
Significant myointimal thickening, consisting of a layer of loose collagen and myointimal cells on 
the tissue surface, could be identified by a second, highly backscattering layer with a well-




Figure 2.7. OCT B-scans (top) and corresponding Trichrome histology (bottom), showing OCT image textures and 
layer patterns corresponding to different endocardial and myocardial compositions. A, Endocardium with thickness 
within OCT depth penetration. B, Endocardium with thickness beyond OCT depth penetration. C, Endocardium with 
myointimal thickening. Dotted yellow lines show representative regions of transition between the endocardium and 
myocardium. Dotted blue lines show representative regions of transition between loose collagen with myointimal cells 
and the endocardium. Scale bars represent 1 mm. e = endocardium; m = myocardium; i = loose collagen and 
myointimal cells; asterisk = imaging artifact from the sample z-Spacer. 
2.3.2 Adipose 
Adipose tissue is highly recognizable within OCT images with a distinct “honeycomb” texture that 
can also become a speckled or brightly dotted texture if further from the imaging focus. Within 
the OCT imaging data of the whole human left atrium, adipose tissue could typically be observed 
in specific locations, which are summarized in Figure 2.8. Adipose tissue was often seen in a thin 
layer underneath the venous media and above the myocardium within the myocardial sleeves, 
shown in Figure 2.8A, as well as in the fibrofatty adventitia of the pulmonary veins as seen in 
Figure 2.8B. Adipose tissue was also markedly visible at the septum. Adipose tissue could exist in 
large pockets that transmurally spanned the atrial wall in thinner regions, shown in Figure 2.8C, 
and was particularly prominent inside and around the crescent wedge at the edge of the fossa 
ovalis. More generally, adipose tissue could be seen distributed throughout the interatrial septum 
in small pockets of varying sizes, as demonstrated in the adipose tissue thickness map of Figure 
2.8E. These pockets could be seen directly underneath the endocardium within OCT, although 





Figure 2.8. Adipose distributions in human left atrial tissue. A, OCT B-scan (top) and histology (bottom) of adipose 
overlying a myocardial sleeve in a pulmonary vein. B, OCT B-scan (top) and histology (bottom) of adipose from the 
fibro-fatty adventitia. C, OCT B-scan (top) and histology (bottom) of adipose tissue within the edge of the fossa 
ovalis. D, En face OCT image at the fossa ovalis, shown 0.26 mm from the endocardial surface, showing adipose 
tissue distributed over a wide area. The white dot corresponds to the location of the B-scan shown in F. E, 
Corresponding adipose thickness map to D. F, OCT B-scan (top) and histology (bottom) of adipose near the fossa 
ovalis. The crosses indicate regions of adipose tissue. 
The amount of adipose tissue as imaged by OCT was variable among hearts, particularly at the 
septum due to the large amount of adipose tissue observed there. Adipose tissue was proliferous 
in some left atria and almost non-existent in others. The total thickness and volume of adipose 
across comprehensively imaged left atria is provided in Table 2.2. The maximum thickness of 
adipose tissue, about 0.4 mm, was typically limited by the imaging depth of OCT. Note that 
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variability in total adipose tissue volume over the whole heart could depend on the length of the 
pulmonary veins that were still intact upon heart acquisition, which varied from specimen to 
specimen. However, the total volume of adipose tissue specifically within the region of the 
interatrial septum also varied greatly. Representative registrations of adipose tissue thickness maps 
to the left atrium model are shown in Figure 2.9. As described previously, adipose tissue could be 
seen to cluster primarily around the septum, with some distributions around the pulmonary veins. 
Adipose tissue distant from these two locations were only observed in heart #14, shown in Figure 
2.9E, which showed significant amounts of adipose tissue spanning a large distance of the left 
atrial wall underneath the left superior pulmonary vein and adjacent to the left atrial appendage.  
Table 2.2. Adipose Measurements 
Heart # Max Thickness (mm) Total Volume (mm3) Total Volume at Septum (mm3) 
9 0.36 4.82 4.82 
10 0.26 2.01 1.69 
12 0.42 18.10 5.69 
13 0.38 11.77 7.52 
14 0.40 28.74 11.57 





Figure 2.9. Adipose thickness distributions in human left atria, as extracted from endocardial OCT images and 
superimposed on a 3D left atrium model. The adipose thickness is shown as a color map, while areas where adipose 
was not seen instead show camera images of the left atrial tissue. The models are shown in four views to show the 
entirety of the left atrium. A, Reference model, showing the location of the pulmonary veins and left atrial 
41 
 
appendage relative to the model’s orientation. B, Adipose thickness distribution from Heart #15. C, Adipose 
thickness distribution from Heart #9. D, Adipose thickness distribution from Heart #13. E, Adipose thickness 
distribution from Heart #14. 
2.3.3 Myofiber Orientation and Collagen fibers 
Collagen fibers within the myocardium could be identified by backscattering strands within 
regions of myocardium. Figure 2.10 shows a stitched image region where fiber organization could 
be identified at sub-endocardial levels. Figure 2.10A shows an en face image still within the 
endocardium, showing a smooth pattern. Figure 2.10B displays a region deeper within the tissue, 
revealing the fiber information, which is also seen in a B-scan view in Figure 2.10C. However, 
fiber orientation could not be identified in regions where the endocardial thickness was beyond the 
imaging penetration depth, as shown in Figure 2.10D. 
 
Figure 2.10. A, En face OCT image, 0.07 mm and B, 0.27 mm from the endocardial surface. C, histology and 
corresponding stitched OCT B-scan in region with rich collagen fiber information; D, histology and corresponding 
stitched OCT B-scan with thick endocardium and less fiber information. 
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When shown in the en face view, striations within the OCT images could be correlated to 
fiber orientation seen in corresponding en face histology images, demonstrated in Figure 2.11A-
B. En face views revealed myofiber and collagen fibers wrapping around pulmonary veins in 
different directions, as shown in Figure 2.11C-D. In particular, in Heart #11, transmural changes 
in myofiber orientation could be clearly observed, shown in Figure 2.11E-F where the fiber 
orientation changed by nearly 60° at different depths. The extracted profile of fiber orientation 
over depth shown in Figure 2.11G shows an abrupt change in fiber orientation, which is consistent 




Figure 2.11. En face OCT and histology images, showing fiber orientation. A, OCT en face image, shown 0.39 mm 
from the tissue surface. B, Corresponding en face histology image. Dotted yellow lines in the OCT image show 
boundaries between regions of endocardium and myocardium. White arrowheads indicate striations indicative of fiber 
orientation in OCT. C, OCT en face image, shown 0.30 mm from the tissue surface.  D, OCT en face image, shown 
0.38 mm from the tissue surface. E, Region within the dotted red box shown in C, at a depth of 0.29 mm. F, Region 
within the dotted red box shown in C, at a depth of 0.17 mm. G, Fiber angle over depth at the point indicated by the 
black asterisk in C. White double-sided arrows indicate general fiber orientation trends. All scale bars indicate 1 mm.  
 To obtain a measure of the maximum endocardial thickness under which myocardial 
features could be visualized with this OCT system, measurements of endocardial thickness were 
obtained in regions where fiber orientation could be seen in the en face OCT images of pulmonary 
vein myocardial sleeves. Out of 32 pulmonary veins in which measurements were made, 23 veins 
had areas of sufficiently thin endocardial thickness to observe fiber orientation in the en face 
images of the venoatrial junction. In 3 left superior, 2 left inferior, 3 right superior, and 1 right 
inferior pulmonary vein, fiber orientation was unable to be observed in the en face OCT images at 
the venoatrial junction. The endocardial thickness measurements are shown in Table 2.3. The 
average thickness under which fiber orientation could be observed was 0.28±0.06 mm as measured 
from OCT, and 0.31±0.08 mm as measured from histology, overall for all veins. The range of 
measurements were 0.15 to 0.43 mm and 0.12 to 0.47 mm for OCT and histology, respectively. 
Table 2.3 Endocardial Thickness, where Myocardium within OCT Imaging Depth 






































Values are given as mean ± standard deviation (range). LIPV: left inferior pulmonary vein; LSPV: left superior 
pulmonary vein; RIPV: right inferior pulmonary vein; RSPV: right superior pulmonary vein; OCT: optical 
coherence tomography 
Representative mappings of fiber orientation, as extracted from manual measurements, to the 3D 
left atrial model are presented in Figure 2.12. Given OCT’s imaging depth, fiber orientation 
information could most often be extracted from the septal region and around the pulmonary veins. 
Consistent with findings from gross inspection and DT-MRI, fibers often wrapped 
circumferentially around the pulmonary vein ostia [58, 121]. Within hearts #13 and #14, fiber 
orientation wrapping around the right pulmonary veins with obliquely running fibers between the 
pulmonary veins and fiber orientation circumferential to the waist of the left atrium underneath, as 
seen on the far right in Figure 2.12D and E, is also consistent with observations from DT-MRI 
data. [58] Overlapping fiber bundles could be seen in high detail, such as seen in the inset of Figure 




Figure 2.12. Fiber orientation in the human left atria, as extracted from OCT images and superimposed on 3D 
anatomical models. A, Reference model, showing the location of the pulmonary veins and left atrial appendage 
relative to the view. B, Fiber orientation from Heart #15. C, Fiber orientation distribution from Heart #9. D, Fiber 
orientation distribution from Heart #13. E, Fiber orientation distribution from Heart #14. 
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2.3.4 Pulmonary Veins 
In regions of the pulmonary veins consisting of the venous endothelium, media, and adventitia, 
the OCT images typically showed a more heterogeneous texture and a deeper penetration depth 
with a gradual fall-off of intensity. The specific texture of the venous tissues could vary between 
pulmonary veins based on the composition and density of fibrous tissues within the region. For 
example, in Figure 2.13A, the venous media and adventitia have a speckled appearance, while 
Figure 2.13B instead shows a highly backscattering upper layer with additional bands underneath. 
Finally, some pulmonary veins consisting of dense connective tissue had a more homogeneous 




Figure 2.13 OCT B-scans (top) and corresponding Trichrome histology (bottom), showing differences in OCT image 
texture corresponding to venous media and adventitia with different densities and distributions of connective tissue. 
A, Venous media and adventitia with a speckled image texture in OCT. B, Venous media and adventitia with a layered 
image texture in OCT. C, Venous media and adventitia with a smooth homogeneous image texture. Scale bars 
represent 1 mm. v = venous media; asterisk = imaging artifact from the sample z-Spacer. 
Given the distinct image features of different tissue compositions as described above, 
regions of myocardial sleeves could be differentiated from pulmonary vein regions containing only 
venous endothelium, media, and adventitia. The transition from myocardium to adventitia, where 
the myocardial sleeve ends, could typically be identified by at least one of two ways. First, the 
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sharp boundary between the endocardium and myocardium became more diffuse when entering 
regions containing only venous media and adventitia, often accompanied by an increase in 
penetration depth. Second, a more heterogeneous image texture was typically seen with venous 
media and adventitia compared to endocardium and myocardium. Representative examples are 
described below, showing how the myocardial sleeves, as well as fibrosis and variations in 
endocardial thickness, could be observed. 
In Figure 2.14, the distinct layer boundary disappears and the penetration depth increases 
once entering the region of only venous endothelium, media, and adventitia, as seen towards the 
right of the B-scan of Figure 2.14B. The en face view in Figure 2.14A also shows a clear difference 
in texture and backscattering between the myocardial region on the left and the region without 
myocardium on the right of the dashed green line. Collagen distributed between myofibers, as seen 
from histology, were identifiable by highly backscattering strands within OCT, with the parallel 
directionality of the fibers clearly defined. The 3D ROI from which texture and fiber orientation 
statistics were extracted is represented in the x-y and x-z planes by the blue boxes in Figure 2.14A 
and Figure 2.14B. The mean local range in the myocardial ROI was 5.37, the mean local standard 
deviation was 1.81, and the mean local entropy was 3.07. The circular standard deviation of 




Figure 2.14. OCT imaging of a venoatrial junction and corresponding histology, showing change in depth 
penetration near the end of the myocardial sleeve. A, Stitched en face region, shown 0.34 mm from the tissue 
surface.  B, Stitched B-scan corresponding to the orange line in A. C, Corresponding Trichrome histology to B. 
Dotted white lines show the approximate location of the PV ostia. Dashed green lines show the approximate area of 
transition from myocardium to venous media and adventitia. Dotted yellow lines show representative regions of 
transition between the endocardium and myocardium. The blue dotted boxes represent the 3D ROI from which 
texture and fiber orientation statistics were calculated. All scale bars indicate 1 mm. LA = left atrium, RIPV = right 
inferior pulmonary vein; e = endocardium; m = myocardium; v = venous media. 
In Figure 2.15, the region containing only venous endothelium, media, and adventitial tissues has 
a more heterogeneous texture, with more variations in intensity and an almost hatched pattern as 
seen in the en face view of Figure 2.15A. The change in image texture is also noticeable in the B-
scan shown in Figure 2.15B, where the region without myocardium includes additional bands 




Figure 2.15 OCT imaging of a venoatrial junction and corresponding histology, showing change in image texture near 
the end of the myocardial sleeve. A, Stitched en face region, shown 0.50 mm from the tissue surface. B, Stitched B-
scan corresponding to the orange line in D. C, Corresponding Trichrome histology to E. Dotted white lines show the 
approximate location of the PV ostia. Dashed green lines show the approximate area of transition from myocardium 
to venous media and adventitia. Dotted yellow lines show representative regions of transition between the 
endocardium and myocardium. All scale bars indicate 1 mm. LA = left atrium, LIPV = left inferior pulmonary vein; 
e = endocardium; m = myocardium; v = venous media. 
As demonstrated previously in Figure 2.13, different pulmonary veins had different 
textures corresponding to the venous endothelium, media, and adventitia, and other pulmonary 
veins had a speckled or striated texture as opposed to the hatched pattern seen above. A 
representative example is shown below in Figure 2.16. Adipose pockets were often observed. Note 




Figure 2.16 OCT imaging and corresponding histology of a venoatrial junction. A, Stitched en-face region, shown 
0.51 mm from the tissue surface.  B, Stitched B-scan corresponding to the orange line in A. C, Corresponding 
Trichrome histology to B. Dotted white lines show the approximate location of the pulmonary vein ostia. Dashed 
green lines show the approximate area of transition from myocardium to venous media and adventitia. Dotted yellow 
lines show representative regions of transition between the endocardium and myocardium. The blue and purple 
markers indicate speckles and striated textures, respectively. LA = left atrium; LIPV = left inferior pulmonary vein; e 
= endocardium; m = myocardium; v = venous media. 
Another representative case showing distinct collagen fiber structure at the venoatrial 
junction is given in Figure 2.17. With OCT imaging, fibrotic myocardium could be identified past 
the pulmonary vein ostium and inside the venous region. The endocardial thickness could be seen 
to abruptly decrease inside the pulmonary vein area and significant focal thickening of 
endocardium was observed near the ostium, as seen in both the en face view in Figure 2.17A and 
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B-scan view in Figure 2.17B. Again, fibrotic collagen fibers could be identified by bright strands. 
Within this pulmonary vein, the fibrotic collagen fibers varied more greatly in size and 
directionality compared to those shown in Figure 2.14A. Similar patterns of complex fibrosis were 
observed in the LSPV and LIPV of heart #13. The depth penetration increases at the far right of 
the B-scan in Figure 2.17D, signaling the end of the myocardial sleeve and transitioning to a region 
containing only the endothelium, venous media, and adventitial tissues. The 3D ROI from which 
texture and fiber orientation statistics were extracted is represented in the x-y and x-z planes by 
the blue boxes in Figure 2.17C and Figure 2.17D. The mean local range in the myocardial ROI 
was 4.88, the mean local standard deviation was 1.65, and the mean local entropy was 2.89. The 
circular standard deviation of extracted fiber orientation angles was 35.17°. 
 
Figure 2.17. OCT imaging of a venoatrial junction and corresponding histology, showing changes in endocardial 
thickness and depth penetration, as well as fibrosis. A, LIPV, prior to dissection. B, LIPV from A, post-dissection. C, 
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En face region, shown 0.39 mm from the tissue surface, corresponding to the red box in B. A zoomed in view of a 
sub-region is shown to show details of the fibrosis patterns. D, Stitched B-scan corresponding to the orange line in C. 
E & F, Corresponding Trichrome histology to D. Dotted white lines show the approximate location of the PV ostia. 
Dashed green lines show the approximate area of transition from myocardium to transmural connective tissue. All 
scale bars indicate 1 mm. Dotted yellow lines show representative regions of transition between the endocardium and 
myocardium. The blue dotted boxes show the ROI from which texture and fiber orientation statistics were calculated. 
LA = left atrium; LIPV = left inferior pulmonary vein; e = endocardium; m = myocardium; v = venous media. 
Endocardial thickness and composition of the venous media and adventitia varied between 
pulmonary veins and among different regions of a single pulmonary vein. There were some cases 
in which it was difficult to distinguish the myocardial sleeves from venous regions without 
myocardium. Figure 2.18 presents two representative cases. In Figure 2.18A, the increase in depth 
penetration due to myointimal thickening could deceptively be interpreted as a region consisting 
of only venous endothelium, media, and adventitia despite myocardium being present underneath. 
In Figure 2.18C, the upper layer boundary becomes more diffuse, but the penetration depth remains 
similar throughout, making identification of the end of the myocardial sleeve unclear. The ability 
to differentiate regions of myocardial sleeves to regions without myocardial sleeves, based on 
qualitative OCT image features, was generally determined for each pulmonary vein by a single 
observer not blinded to the histology. Out of 32 pulmonary venoatrial junctions, it was determined 
the myocardial sleeves could be differentiated from venous regions without myocardial sleeves in 
18 cases while 6 cases were ambiguous. In the remaining 8 cases, the pulmonary veins had been 
cut short such that only the myocardial sleeves could be imaged, with no transition to venous 




Figure 2.18. Cases where identification of pulmonary vein sleeves is ambiguous in OCT imaging. A, OCT B-scan 
near the LIPV from heart #15. B, Corresponding Trichrome histology to A. C, OCT B-scan near the LSPV from heart 
#12. D, Corresponding Trichrome histology to C. Dotted yellow lines show representative regions of transition 
between the endocardium and myocardium. Dotted blue lines show representative regions of transition between loose 
collagen with myointimal cells and the endocardium. Dashed green lines show the approximate area of transition from 
myocardium to transmural connective tissue. All scale bars indicate 1 mm. e = endocardium; m = myocardium; i = 
loose collagen and myointimal cells.  
In a few hearts, the adventitial side of the pulmonary vein was also imaged with OCT, and a 
representative figure is given in Figure 2.19. From the adventitia, OCT is able to capture the 
profuse regions of adipose tissue, covered by a layer of loose collagen, as well as the fibrous areas 




Figure 2.19. OCT imaging of the adventitial side of the pulmonary vein. A, Trichrome histology, and B, 
Corresponding OCT image. 
2.3.5 Interatrial Septum 
As described above, adipose tissue was often observed at the septum. The amount of adipose tissue 
at the septum could vary widely. In particular, it was noted in certain hearts, regions of abundant 
adipose and fibrous tissue at the fossa ovalis, visible from the white light images, could be imaged 




Figure 2.20. Representative example of significant amounts of adipose and fibrotic tissue at the fossa ovalis. A, 
Camera image of region of interest at the fossa ovalis. B, En face OCT image of the region depicted in the red box in 
A. C, OCT B-scan of the orange line in B. D, Corresponding histology to C. 
Fiber orientation could also often be seen in varying patterns at the septum, with overlapping fiber 




Figure 2.21. Fiber orientation as seen at the septum, shown 0.37 mm from the endocardial surface. 
Notably, unlike in most regions of the left atrium, a transmural view of the left atrial wall could be 
seen in thinner regions of the fossa ovalis, as shown in Figure 2.22. The brighter layers of 
connective tissue could be seen on both sides of the myocardium. 
 
Figure 2.22. Structures at the left atrial fossa ovalis as seen transmurally by OCT. A, OCT B-scan at the edge of the 
fossa ovalis. B, Corresponding histology to A. C, OCT B-scan at the fossa ovalis. D, Corresponding histology to C. 
Scale bars indicate 0.5 mm. Asterisks indicate regions of myocardium. Arrowheads point to the endocardium on 
both sides of the wall. 
2.3.6 Ablation Lesions 
While work has been done in identifying ablation lesions using OCT, the imaging of ablation 
lesions within human left atrial tissue has not yet been evaluated. Therefore, a preliminary study 
of OCT imaging of ablation lesions in the human left atrium was carried out. Within OCT, the 
ablation lesions could correspond to regions of slightly greater penetration depth, as shown in 
Figure 2.23. However, the features were subtle and may not correspond to the full width of the 
lesion. The features of the ablation lesion were also dependent on the surrounding endocardial 
thickness and composition. While image processing may be able to reveal more unique 





Figure 2.23. OCT imaging of ablation lesions within human left atrial tissue. A, En face OCT 
image, shown 0.38 mm from the endocardial surface. B, B-scan corresponding to the orange line 
in A. 
2.3.7 Whole Human Cardiac Atlas 
OCT imaging of the human left atrium contributes to a larger dataset including OCT imaging data 
from 50 human hearts. The donor characteristics for the whole human cardiac OCT dataset is 
provided in Table 2.4. Image features from OCT imaging of all chambers were evaluated both 
quantitatively and qualitatively.  





Age in yrs, median (interquartile range) 62 (57.3– 67.0) 
Female, n (%) 23 (46.0) 
BMI, median (interquartile range) 30.4 (25.71 –36.01) 
Medical History, n (%) 
 
Heart Failure 10 (20.0) 
Cardiomyopathy 7 (14.0) 
Coronary artery disease 11 (22.0) 
Myocardial infarction 7 (14.0) 
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Atrial fibrillation 5 (10.0) 
Chronic obstructive pulmonary disease 17 (34.0) 
Diabetes 16 (32.0) 
Hypertension 34 (68.0) 
Cause of death, n (%) 
 
Cardiac arrest 17 (34.0) 
Cardiopulmonary arrest 6 (12.0) 
Respiratory arrest 3 (6.0) 
Respiratory failure 4 (8.0) 
Chronic obstructive pulmonary disease 3 (6.0) 
Congestive heart failure 3 (6.0) 
 
2.3.7.1 Features within Ventricles 
Examination of ventricular OCT images revealed unique features for various tissue types as shown 
in Figure 2.24. Figure 2.24 A-F show images from ventricular free wall and Figure 2.24 G-L show 
images from the ventricular septum. In healthy hearts as shown in Figure 2.24A, D and G, L, the 
endocardium exhibited a narrow and highly backscattering band at the uppermost region of the 
tissue. The myocardium regions revealed a homogenous pattern in a darker region underneath. 
Fibrous infiltration was observed in both ventricular free wall and septum, as shown in Figure 
2.24B, E and H, K, with rich collagen content within the myocardium. In diseased hearts with scar, 
a thickened endocardium as shown in Figure 2.24C, F was observed. In OCT, the scar region was 
represented by a highly backscattering region with a heterogeneous distribution of collagen density 
indicated by slightly varying intensity. In addition, adipose tissue, which is clearly identifiable by 
a honeycomb texture, occasionally exists in the ventricular septum, as shown in Figure 2.24I, L. 





Figure 2.24. OCT images and corresponding histologic images of multiple substrates within (A-F) ventricular free 
wall and (G-L) ventricular septum. 
2.3.7.2 Features within Right Atria 
In the right atria, Figure 2.25, the endocardial band is typically narrower than those in left atria but 
thicker than those in ventricle. Due to the thinner endocardium, which allows photons to penetrate 
deeper, the myocardium in the right atria often corresponds to a higher intensity in OCT than in 
the left atria. Adipose tissue, again displaying a honeycomb structure, could also be observed in 
the right atria. 
 
Figure 2.25. OCT images and corresponding histologic images of multiple substrates within the right atrium. 
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2.3.7.3 Fibrosis from All Chambers 
Over the whole human heart, we visually observed different OCT image features when fibrosis 
was present in myocardial regions. Collagen within the myocardium could sometimes be seen in 
OCT images as higher intensity regions. For example, as shown in Figure 2.28A, E, collagen fibers 
running alongside the myofibers could be seen in OCT as bright, discrete strands. This is also 
demonstrated within the en face images of Figure 2.28I and J, with bright striations and patches 
corresponding to collagen regions. However, in other cases, fibrosis patterns were seen 
corresponding to decreased penetration depth, as shown in Figure 2.28(B-D, F-H). Fibrotic regions 
with low backscattering in comparison with the surrounding myocardial region could be seen for 
both diffuse and compact fibrotic regions, as seen in Figure 2.28(B-D, F-H). In some cases, 
corresponding OCT features to fibrosis as seen from histology were not visually apparent, such as 
seen in the above Figure 2.25D. 
 
Figure 2.26. OCT images and the corresponding histologic images of fibrosis, showing various fibrosis patterns. A, 
E, Interstitial fibrosis, with collagen fibers running alongside myofibers; B, F, low level of diffuse fibrosis; C, G, 
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higher level of diffuse fibrosis; D, H, compact fibrosis region.  Panels I-J show fibrosis as seen in the en face plane. 
(A, E, I, J) are from the atria and (B-D, F-H) are from the ventricle.   
2.3.7.4 Statistical Analysis 
We performed a statistical comparison of quantitative features extracted from the OCT 
images. We first compared the difference in OCT images from different chambers. Three 
representative features from optical properties (attenuation coefficient), texture (correlation), and 
pixel distribution (standard deviation) are presented in Figure 2.27. In general, we found the 
features had a strong correlation with the different chambers. For example, in attenuation 
coefficient, Figure 2.27A, features were significantly different except the pairs that were from the 
same chamber (left ventricle vs left ventricular septum, right ventricle vs right ventricular septum) 
and the same type of chamber (left atrium vs right atrium and left ventricle vs right ventricle). 
Other similarities, such as left ventricular septum vs left atrium and right ventricle vs right 
ventricular septum, were also identified by correlation and standard deviation, with these two 
chambers showing no significant difference in the multi-comparison test after ANOVA for these 
features. Notice that no single extracted feature could uniquely identify a chamber. There was no 
significant difference when comparing left ventricular septum vs right atrium in correlation and 




Figure 2.27. Statistical analysis of three representative features. A, attenuation coefficient, B, texture correlation, and 
C, standard deviation, extracted from human cardiac OCT images. Comparisons were made within all chambers. 
We also examined the difference in quantitative features among different tissue types. 
Figure 2.28 shows the statistics within atria (A-C) and ventricles (D-F). We found that adipose 
tissue was significantly different from all other tissue types in attenuation coefficient, correlation, 
and standard deviation in both the atria and ventricles. In ventricle, collagen and fibrotic 
myocardium were not significantly different in correlation, but were significantly different in 




Figure 2.28. Statistical analysis of three representative features. A, D, attenuation coefficients, B, E, texture 
correlation, and C, F, standard deviation, extracted from human cardiac OCT images. Comparisons were made 
within all substrates in (A-C) atria and in (D-F) ventricle. 
2.4 Discussion 
This study is the first, to the authors’ knowledge, to present comprehensive OCT imaging data of 
the whole human left atrium, which is also a subset of a whole human cardiac OCT imaging atlas. 
Given its high-resolution, OCT is capable of providing details of cardiac tissue structure that 
cannot be captured by current cardiac imaging modalities. The human cardiac OCT imaging atlas 
described within this study provides a basis for future OCT applications in investigating diseases 
of the human heart. Imaging criteria and distributions for different tissue types including 
myocardial sleeves, venous media, adipose tissue, endocardial and myointimal thickening, and 
fibrosis were provided for the human left atrium and pulmonary veins. OCT imaging of human 
left atrial tissue could provide additional information of the structural substrate of atrial fibrillation 
and potentially assist in guiding atrial fibrillation ablation procedures. Additionally, the cardiac 
OCT imaging atlas provides a reference for training future interpretation and processing of cardiac 
OCT imaging data. Rules for identifying tissue features from the OCT imaging data, developed 
from this study, are provided in the Appendix. 
2.4.1 Applications to the Study of Atrial Fibrillation 
There has been recent interest in the use of OCT to guide atrial fibrillation ablation therapy, 
specifically in imaging of ablation lesion formation [111-114, 116]. Using OCT-integrated 
catheters, regions of complex fiber orientation or fibrosis imaged by OCT could be associated to 
electrical conduction patterns, in vivo. Given the varying biophysical properties of different tissue 
compositions, endocardial thickness, fibrosis, adipose tissue, and myointimal thickening could 
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also be taken into consideration when choosing ablation targets. OCT imaging of the human left 
atrium could also be applied to basic science applications, such as correlating the tissue structure 
identified by OCT to certain disease states, given a larger sample size of hearts with atrial 
fibrillation. The tissue structure identified by OCT data could also be incorporated into tissue-
specific, electrophysiological models to better understand the influence of tissue microstructure on 
atrial fibrillation dynamics, as will be described in the following chapters. 
2.4.2 Influence of Imaging Depth  
The main limitation of OCT is its imaging depth, which is determined by attenuation from optical 
scattering and absorption within the tissue [81]. Limitations are also posed by the OCT system 
sensitivity, which was 100 dB at 28 kHz with a roll-off of 5 dB at 2.26 mm for this imaging system. 
In the case of cardiac tissue, imaging of myocardial features of interest such as fiber orientation 
and fibrosis is limited by the thickness and density of overlying endocardium or venous media. In 
this study, it was found that myocardial features could be visualized under overlying endocardial 
thicknesses averaging 0.28 mm for OCT measurements and 0.31 mm for histology measurements, 
respectively. 
OCT enables identification of endocardial thickness with resolution that cannot be 
achieved by other commonly used cardiac imaging modalities. In areas of thicker endocardium, 
however, the lower boundary of the endocardial layer in OCT disappears, limiting the ability to 
accurately measure endocardial thickness. Nonetheless, the knowledge of when the endocardium 
exceeds a certain thickness could still be useful for understanding the properties of tissue being 
ablated. For ex vivo applications, OCT imaging of the transmural atrial wall could be made possible 
through the use of optical clearing, imaging from both endocardial and epicardial surfaces, or thick 
sectioning of the tissue. 
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For investigation of detailed tissue architecture in vivo, however, initial applications of 
OCT may be most suitable for imaging the pulmonary veins and the interatrial septum. The 
maximum thickness of overlying connective tissue under which myocardial features could be seen 
were 0.43 mm for OCT and 0.47 mm for histology. The thickness of the endocardium and venous 
media at the venoatrial junction has been determined from ultrasound and histology to range from 
0.05 to 1.7 mm at the venoatrial junction and decrease to a range of 0.0 – 0.3 mm at 2 cm from the 
orifice towards the lung hilum [68]. Therefore, OCT is still applicable for a considerable range at 
the pulmonary veins. Furthermore, as demonstrated in this study, OCT imaging can penetrate the 
majority of the thickness of the thin region of the fossa ovalis. 
2.4.3 Tissue Architecture of the Venoatrial Junction 
The structure of the pulmonary vein myocardial sleeves have been identified through histological 
studies to be highly complex. Ho et al. described an intricate arrangement of both circular and 
longitudinal myofiber bundles, with gaps and fibrosis commonly observed within the myocardial 
sleeves [127]. The structure of the pulmonary veins are also variable among different hearts and 
between individual veins. Saito et al. in particular identified some pulmonary veins having a more 
regular and aligned arrangement of myofibers, while others had non-uniform, crossing patterns 
[130]. Due to its complicated and unique structure, high resolution imaging is needed to fully 
capture the pulmonary vein structural substrate. This study demonstrated that OCT is able to image 
similar myocardial sleeve features as seen from histology. In particular, OCT was able to visualize 
the orientation and density of myofibers and collagen fibers, which varied between veins. For 
instance, the parallel organization of myofibers and collagen fibers seen in Figure 2.14 can be 
contrasted to the more complex organization seen in Figure 2.17. Quantitative analysis showed 
that the myocardial and collagen fiber region seen in Figure 2.14 had higher average local range, 
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standard deviation, and entropy, but lower circular standard deviation of fiber angles than the 
region from Figure 2.17. This was likely because the myocardial and collagen fiber region seen in 
Figure 2.14 consisted of thinner, yet more organized fibers, in contrast to the larger and more 
disorganized collagen fibers seen in Figure 2.17. Such analysis shows promise of quantitative 
metrics of fiber and fibrosis complexity from OCT images in the future. Finally, fiber orientation 
running in crossing directions were observed over different depths, as demonstrated in Figure 2.11. 
2.4.4 Tissue Architecture at the Interatrial Septum 
The leading cause of aborted transseptal puncture procedures has been cited to be difficulty in 
identifying the location of the fossa ovalis. [141] As it was shown within this study that thin regions 
of the fossa ovali can be identified and imaged transmurally with OCT, it is possible that OCT 
imaging could be used as an adjunctive tool to assist in the identification of the fossa ovalis for 
transspetal puncture. Furthermore, the septum has been reported as one of the common locations 
for non-pulmonary foci for atrial fibrillation. [38] As myofiber orientation as well as significant 
distributions of adipose tissue could frequently be identified at the interatrial septum with OCT, it 
is possible that OCT could provide further information useful for understanding structural 
influences on arrhythmia dynamics. Increased adipose at the interatrial septum is associated with 
atrial fibrillation. [65, 142] While catheter-based, in vivo OCT imaging would only able to 
determine distributions of adipose tissue near the surface, further study could potentially delineate 
if the total volume of OCT-imaged adipose correlates to the overall adiposity of the interatrial 
septum.  
2.4.5 Limitations and Future Work 
With regards to in vivo applications, a limitation is that this study was carried out ex vivo. In vivo 
imaging would pose additional challenges due to heart and catheter motion, as well as the need for 
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real-time mapping and stitching to visualize large fields of views. Thus, future in vivo studies 
would be required to determine if the same features described in this study can be visualized during 
ablation. Prior studies in swine, however, have demonstrated the capability of OCT-integrated 
catheters to image the atrial endocardium and myocardium in vivo [113, 114].  
Additionally, while the majority of the left atrial tissue was imaged for mapping, due to the 
manual nature of imaging and limitations of the imaging setup, some regions of tissue were not 
imaged at the edges of the tissue. Furthermore, the size and morphology of human hearts differ, 
including the left atria. Therefore, more precise mapping to atrial geometry would require 
personalized meshes of the left atria, such as could be obtained from MRI or CT. 
During image pre-processing, it is possible that the contact glass surface of the sample z-
Spacer, when completely adjacent with the endocardial surface, could not be distinguished from 
the endocardium, potentially affecting endocardial measurements in some cases. As an estimate of 
the potential error, the thickness of the z-Spacer surface seen in OCT was measured from one B-
scan and found to be about 0.04 mm. 
In this study, endocardial thickness measurements were sampled from three different points 
within the regions of interest to characterize the overall trend. Representative quantitative myofiber 
texture and angle measurements were also taken from selected ROIs. In the future, automated 
methods [95, 118, 143] can be more comprehensively applied to quantitatively evaluate 
endocardial thickness and other tissue features, such as myointimal thickening and fiber 
orientation, over the entire imaged region. Further studies would also be needed to more 




For the whole human heart cardiac atlas, statistical analysis was carried out on small 
regions of interest within each B-scan. More discriminating features could be possible by carrying 
out statistical analysis on fully segmented OCT image volumes. The data from the human cardiac 
OCT imaging atlas can also be analyzed further to identify correlations between imaged tissue 
structures and disease. Finally, only a few donors in the left atrial imaging study had a history of 
atrial fibrillation, and additional OCT imaging in hearts from donors with atrial fibrillation would 
be necessary to determine further applicability to atrial fibrillation ablation.  
2.5 Conclusion 
This study demonstrated that OCT can provide detailed visualization of tissue architecture in the 
human left atrium. Structural features such as myocardial sleeves, fiber orientation, fibrosis, 
adipose tissue, endocardial thickness, and myointimal thickening were identified from the OCT 
images and mapped to left atrial geometry. Imaging of detailed tissue architecture could assist in 
the guidance of ablation procedures and improve the understanding of the structural substrate of 
atrial fibrillation. More generally, OCT imaging of cardiac tissue over the whole human heart 




Chapter 3 Workflow for the Development of 
OCT-Informed Cardiac Models 
3.1 Introduction 
Optical mapping is an experimental technique that uses voltage-sensitive dyes to track changes in 
transmembrane potential in cardiac tissue using fluorescence. Optical mapping can be carried out 
on cultured myocyte monolayers, [144] sections of cardiac tissue, [145] or on whole hearts through 
panoramic mapping techniques. [146] During optical mapping, cardiac tissues are stained with 
voltage-sensitive dyes which bind to the cardiac cell membranes. The magnitude of fluorescence 
emitted by the dye at a specific emission wavelength changes with the depolarization and 
repolarization of the cardiac cell, thus providing a signal that is proportional to changes in 
transmembrane potential. Therefore, cardiac action potentials can be tracked by collecting emitted 
fluorescent light at the target emission wavelength through the use of optical filters.  The most 
popular dyes are the styryl dyes, such as Di-4-ANEPPS and Rh-421 [147-149]. An optical 
mapping setup requires a light source, such as tungsten-halogen bulbs, laser light, or light-emitting 
diodes; a detector, such as photodiode arrays, charge coupled device cameras, and complementary 
metal-oxide semiconductor cameras; and optical filters to reduce background light and obtain the 
desired excitation and emission wavelengths. [148]  
While optical mapping enables tracking of the spatiotemporal dynamics of cardiac 
electrophysiology, there have been differences observed between electrode recordings and optical 
mapping recordings of action potentials. For example, the optical action potential typically has an 
elongated upstroke compared to the electrical action potential, with the optical action potential 
having been recorded to be about up to five times longer than its electrical counterpart. [150] Other 
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discrepancies have been observed in the optical mapping signals, such as elevated resting 
potentials during arrhythmia, [151] dual-humped action potentials, [152] and decreased magnitude 
of virtual electrode polarization induced by defibrillation-strength shocks. [75] These phenomena 
are related to the scattering and integration of the optical mapping signal over depth and have 
prompted further investigation into how optical mapping signals manifest. For this reason, 
computational models that simulate optical mapping signal synthesis have been developed. Such 
models have enabled further insights in how the morphology of optical mapping signals relate to 
subsurface electrophysiological distributions. For example, Hyatt et al. discovered through 
computer simulation, and later through verification with optical mapping experiments, that the 
shape of the optical action potential upstroke is related to the angle of propagation of the subsurface 
electrophysiological wave relative to the tissue surface. [71, 153] Bishop et al. identified, through 
simulations of arrhythmia and optical mapping on an anatomically realistic rabbit ventricular 
model, that the location of phase singularities were shifted in optical mapping signals compared to 
the transmembrane potential distributions. [74] Findings such as these enable improved 
interpretation of optical mapping signals, and open up possibilities of extracting valuable 
intramural information of electrical patterns from optical mapping signals. 
Optical mapping models are developed by combining electrophysiological simulations 
with optical simulations of excitation and fluorescent emission. Optical simulations have been 
carried out using photon diffusion theory. [71]  However, Monte Carlo photon scattering 
simulations have been shown to provide more realistic results, [154]  and are more useful for 
models incorporating complex, heterogeneous tissue structure. [76] The majority of prior optical 
mapping models have been developed with simplistic shapes and homogeneous tissue regions. 
However, realistic tissue models are critical for understanding electrophysiological dynamics. In 
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this chapter, we develop a modeling workflow for creating tissue-specific optical mapping models 
derived from OCT imaging. The general workflow for simulating optical mapping in OCT-
characterized atrial models is described in Figure 3.1. Structural features, such as fiber orientation, 
location of ablation lesions, and distribution of different tissue types, were extracted from the OCT 
volumetric data of the tissues and used to develop the tissue-specific models. After construction 
of the models, electrophysiology and excitation photon scattering were simulated, and the resulting 
transmembrane potential and excitation photon density data were used to generate the fluorescent 
sources that produce the optical mapping signal. In the final step, fluorescent light propagation 
was simulated to produce the optical mapping signal in the atrial tissue models. 
 
Figure 3.1 Flow diagram for optical mapping modeling of atrial tissue as derived from OCT images. Vm is normalized 
transmembrane potential, Iex is normalized excitation photon density, and Iem is fluorescent emission photon density. 
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3.2 Image Processing 
3.2.1 Tissue Geometry and Tissue Composition Extraction 
Tissue geometry and composition must first be extracted from the OCT images to be incorporated 
into the mesh geometry and model parameters. This includes extraction of the tissue surfaces and 
features including myofiber orientation and distribution of different tissue types. Extraction of 
tissue geometry is carried out through the detection of the tissue surfaces. The identification of 
tissue surfaces from OCT images can typically be accomplished using gradient and thresholding 
techniques due to the high contrast between the background and surface of the tissue in OCT. The 
specific parameter and processing steps of tissue surface detection, however, may vary between 
different OCT image volumes based on the imaging system used and the presence of artifacts. 
More detailed steps will be provided for each specific dataset in Chapter 4. Myofiber orientation 
can be extracted using a previously described automated method. [95] The lateral boundary of 
ablation lesions can be estimated using previously described image processing techniques [115] or 
through manual segmentation. The appearance of the birefringence artifact, which disappears in 
regions of ablated tissue, [109, 110, 115] or the decreased contrast between the endocardium and 
myocardium, as well as the disappearance of collagen fibers within the lesion, can be used as 
features to identify the lesion contours in the lateral dimensions. Currently, there is no method to 
estimate lesion depth from OCT. Therefore, lesion depth must be estimated from 
triphenyltetrazolium chloride (TTC) staining and histology. Regions of myocardium, 
endocardium, and adipose tissue can be segmented manually based on the known image features 
of those tissue types. 
3.2.2 Lesion Contour Estimation 
For modeling, the shape of the lesion was estimated from the lateral boundaries as derived from 
OCT imaging and the maximum depth of the lesion as identified from TTC and histology. 
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Elliptical arcs were used to estimate the contour of the lesion in depth, based on the ellipsoidal 
shape of lesions as reported in literature [155], as well as from individualized observations of each 
lesion sample. For non-transmural lesions, the maximum depth of the lesion was assumed to be at 
the center of the lesion. For each B-scan, points on the outer boundaries of the lesion in the x-
dimension were identified, as well as a point located midway between the two outer boundary 
points and at the desired depth of the lesion for the current B-scan. From these three points, two 
quarter-elliptical arcs were used to estimate the lesion contour in depth, with the ends of one arc 
being the leftmost boundary point and the maximum depth point, and the ends of the second arc 
being the rightmost boundary point and the maximum depth point. The maximum depth for each 
B-scan was similarly constructed by two elliptical quarter-arcs, except with the elliptical arcs 





Figure 3.2. Lesion depth boundary estimation for non-transmural lesions. A, Overall depth boundary estimation. B, 
Depth boundary estimation for a single B-scan. 
For transmural lesions, the lateral boundary of the lesion at the upper surface of the tissue was 
assumed to be the same as on the bottom surface of the tissue. Therefore, for each B-scan, the 
lesion boundary in depth was estimated using two half-elliptical arcs, with the end points of the 
arcs located on the upper and lower surfaces of the tissue. The increase in the lateral boundary 
seen half-way through the depth of the lesion was estimated from TTC and histology and was the 
minor axis of the elliptical arc. This is illustrated in Figure 3.3. 
 
Figure 3.3 Lesion depth boundary estimation for transmural lesions. A, Overall depth boundary estimation. B, Depth 
boundary estimation for a single B-scan. 
3.3 Mesh Generation 
Once the tissue geometry is extracted from the OCT image volume, a mesh must be created with 
the same geometry. Two different simulation schemes were used for electrophysiological 
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simulation and photon scattering simulation. For the electrophysiological simulation, Continuity 
6 [156], a multi-scale modeling finite element package distributed by the National Biomedical 
Computation Resource, was used. Continuity 6 uses a hexahedral mesh for simulation. For photon 
scattering simulation, the Monte-Carlo optical simulator TIM-OS [157] was used. TIM-OS uses a 
tetrahedral mesh for simulation. Therefore, both a hexahedral mesh and a corresponding 
tetrahedral mesh were required for the modeling workflow. 
3.3.1 Hexahedral Mesh 
The nodes of the hexahedral mesh corresponding to the tissue surfaces were generated by sampling 
the segmented tissue surface data with the desired node spacing. The desired spacing of the nodes 
was dictated by the desired conduction velocity and convergence parameters, as will be discussed 
in Section 3.4. After the mesh surfaces of the upper and lower surfaces of the tissue were generated, 
the mesh was divided in the axial direction by refining within Continuity 6. Discretization of the 
mesh in the axial direction was non-uniform because of variations in thickness of the tissue. 
Therefore, the mesh was refined in the axial dimension such that the maximum distance between 
two adjacent nodes in the axial direction was equal to or less than the element edge length used for 
the lateral dimensions. Myofiber orientation could be fitted to the mesh using the built-in 
Continuity 6 fitting module or through 3D interpolation, with the angle data being extracted as a 
set of points, each with an x-y-z coordinate within the model spatial domain and the corresponding 
angle value. Assignment of different tissue types could be accomplished in a similar fashion. This 




Figure 3.4 Hexahedral mesh generation procedure. 
3.3.2 Tetrahedral Mesh 
Tetrahedral meshes were generated with the open-source 3D surface and volumetric generator, 
iso2mesh [158]. The edge length of the tetrahedron was set to be on the order of the step-size of a 
photon packet, which is determined by the optical absorption and scattering parameters of the 
medium. [159] Each tetrahedral mesh of cardiac tissue was generated with a surrounding 
rectangular region of perfusate, as shown in Figure 3.5. This was accomplished by generating a 
surface mesh corresponding to the tissue geometry as well as a surrounding rectangular surface 
mesh, merging the two surface meshes, and converting to a volumetric mesh. The optical 
parameters of the perfusate were set such that the light was not absorbed within the perfusate 
region and was only scattered forward in a straight line, with the anisotropy coefficient g = 1, as 
has been done in previous optical mapping models using TIM-OS. [76] The refractive index of the 
perfusate region was set to 1.3. The models also included a region of air surrounding the perfusate 
that had a refractive index of 1. 
 
Figure 3.5 Tetrahedral mesh of cardiac tissue with surrounding perfusate. 
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3.4 Electrophysiological Modeling 
The Fenton Karma ionic model with atrial parameters was used with the monodomain model for 
all electrophysiology simulations. [160, 161] The necessary mesh discretization for a desired 
conduction velocity was determined by first testing electrophysiological simulations on a 3D 
rectangular strip. The 3D rectangular strip was swept over different element step sizes while 
maintaining the same aspect ratio, 100 by 8 by 4 elements. For a given diffusivity, discretizations 
of the mesh ranging from about 0.05 to 2 mm element step sizes were tested with a planar wave 
traveling from one end of the strip to the other. The resulting conduction velocity was computed 
for each element step size by measuring the activation times along the length of the strip, and the 
maximum element step size with which the conduction velocity converged, or smaller, could be 
used for simulations. Because diffusivity is proportional to the square of the conduction velocity, 
the diffusivity for a new desired conduction velocity could be identified based on one known 
diffusivity and corresponding converged conduction velocity. For different tissue types, the 
diffusivity of nodes within different tissue regions could be adjusted accordingly. If necessary, 
further tuning was carried out for each individual model by additional adjustments of element and 
time step sizes. 
3.5 Optical Mapping Modeling 
The transmembrane potential data from the electrophysiology simulations are coupled with 
simulated excitation photon density data and then used as input to a fluorescent light scattering 
simulation to model the optical mapping signals. The Monte-Carlo optical simulator TIM-OS 




3.5.1 Simulation of Tissue Excitation 
During optical mapping, the tissue is first illuminated to excite the fluorescent dye. To simulate 
uniform illumination, photons were emitted from the upper surface of the perfusate, which was a 
flat layer positioned over the tissue mesh, with a uniform photon density. The number of photons 
emitted per triangle element was determined by a given excitation photon density, or number of 
photons emitted per unit area for illumination, scaled by the area of the triangle. To determine the 
excitation photon density necessary for a converged simulation, the maximum allowable number 
of photons emitted per element was swept from about 10 to 100,000 photons. The simulation was 
run 5 times for each maximum emitted photon value. The standard deviation of the resulting 
volumetric fluence in the tissue mesh was computed for each parameter value, and convergence 
was determined when the overall standard deviation was about equal to or less than 0.05. The 
resulting photon density within the tetrahedral elements represented the illumination intensity 
stored within the tissue. 
3.5.2 Simulation of Fluorescence Emission 
Following illumination, the fluorescence of the voltage-sensitive dye must be simulated to 
synthesize the optical mapping signal. The intensity of fluorescent emission from a specific 
location within the tissue is proportional to the magnitude of excitation light and transmembrane 
potential at that location. To simulate fluorescent emissions, photons were emitted in an isotropic 
fashion from each tetrahedron in the mesh. The number of photons emitted per tetrahedral element 
was calculated by scaling a maximum fluorescence photon density, or maximum number of 
photons emitted per unit volume for fluorescent emission, by the tetrahedron’s normalized 
excitation photon density, normalized transmembrane potential, and the tetrahedron volume. To 
obtain the normalized excitation photon density, the volumetric fluence stored within each 
tetrahedron from the illumination simulation was subsequently scaled from 0 to 1 by normalizing 
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with respect to the maximum volumetric fluence within the tissue region of the mesh. To obtain 
the normalized transmembrane potential, the voltage at that location was also scaled from 0 to 1, 
normalized with respect to the maximum action potential voltage. The voltage assigned to a 
tetrahedron was determined by interpolation of the 3D distribution of voltage as calculated on the 
hexahedral mesh to the centroids of the elements of the tetrahedral mesh. For each point in time in 
the electrophysiological propagation simulation, a separate field of fluorescent sources needed to 
be generated for another Monte Carlo fluorescent photon scattering simulation due to the changing 
voltage distribution. 
3.6 Conclusion 
We have developed a workflow for generating OCT-derived, tissue specific models for 
electrophysiological and optical mapping simulation. The workflow can be applied to OCT 
imaging data of any cardiac tissue, including tissues with heterogeneous composition. With the 
provided methodology, OCT-informed optical mapping models can be utilized to investigate the 
relationship between complex tissue structure as imaged by OCT and electrophysiological 
function, as well as enable more direct comparisons to optical mapping experimental data through 
optical mapping simulations. With the high resolution imaging of OCT, OCT-informed modeling 
provides the potential to investigate the functional influence of tissue microstructure in more detail 




Chapter 4 OCT-Informed Models of Atrial 
Tissue with Electrophysiology and Optical 
Mapping Simulation 
4.1 Introduction 
To investigate structure-function dynamics with OCT, structural information from OCT has been 
used in combination with optical mapping. In a study by Hucker et al., tissue specific structure 
identified by OCT imaging was correlated to multilayer electrical conduction and the location of 
reentry cores during arrhythmia. Different fiber orientation patterns seen at different depths of the 
tissue, as imaged by OCT, could be correlated to the electrical activation patterns observed from 
optical mapping. Additionally, the location of optically mapped reentry cores were associated with 
tissue regions where shifts in dominant fiber angle distributions were identified at different tissue 
depths by volumetric OCT imaging. [107] Thus, structural information from OCT has been 
demonstrated to assist in the interpretation of optical mapping signals. The correspondence 
between optical mapping measurements and OCT structural information motivates the 
development of OCT-informed computational models for optical mapping simulation, which may 
enable more precise correlations of experimental 2D optical mapping data to 3D imaging data. As 
interpretation of optical mapping signals may be complicated by interactions with heterogeneous 
tissue structure, [72, 76] tissue-specific, computational modeling of optical mapping has been 
developed to enable a deeper understanding of the influence of structural heterogeneities on the 
formation of optical mapping signals. 
Prior modeling studies have investigated the effects of ventricular tissue thickness, fiber 
orientation, and tissue geometry on optical mapping signals. The influence of varying tissue 
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thickness on optical signal morphology, in slab models ranging from 2.5 to 10 mm thickness, as 
well as in models simulating trabeculation of the ventricular endocardium, have been previously 
investigated. [153, 154, 162] The effect of ventricular fiber orientation patterns has been analyzed 
in slab models [71, 145, 154] and cylindrical models. [153] Whole rabbit ventricular models, with 
ventricular anatomy and fiber orientation informed by serial sectioning, have been used to assess 
the effect of tissue structure on optical signal morphology during pacing, arrhythmia, and 
defibrillation. [72, 74, 75] Additionally, a model of a rabbit ventricular wedge, using high-
resolution MRI to inform tissue geometry and histologically-informed fiber orientation, has been 
developed to investigate the effect of tissue structure, specifically vein cavities, on the optical 
signal [76]. To the authors’ knowledge, there are currently no optical mapping models focusing on 
atrial structure or utilizing the high-resolution three-dimensional structural information that can be 
offered by OCT. 
In this chapter we present, to our knowledge, the first use of high-resolution OCT 
volumetric data to develop tissue-specific atrial models. We developed atrial models including 
tissue-specific fiber orientation extracted from OCT imaging, ablation lesions which utilized OCT 
to determine the lesion boundaries within the tissue geometry, and heterogeneous tissue types 
including adipose and endocardium. Four different swine atrial samples and one human left atrial 
sample were used to demonstrate the incorporation of OCT-derived structural features into optical 
mapping models. 
4.2 Methods 
4.2.1 Tissue Acquisition and Dissection Protocol 
Swine and human atrial tissues were acquired for modeling. Fresh swine hearts were obtained from 
a local butcher. Diseased human hearts were acquired under an approved protocol from the 
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National Disease Research Interchange. Recovery of human hearts was completed within 24 hours 
after death, and the hearts were delivered to the lab while submerged in an ice-cold phosphate-
buffered saline bath. From the hearts, tissue regions up to about 8.5 mm in lateral dimension were 
dissected for imaging. In this study, five different models were developed from the tissue samples: 
(1) a model of swine left atrial tissue with tissue-specific fiber orientation and tissue geometry as 
extracted from OCT, (2) a model of swine left atrial tissue from a larger stitched region, including 
an area of sharp myofiber orientation change, (3) a model of swine right atrial tissue with a non-
transmural lesion region, (4) a model of swine right atrial tissue with a transmural lesion region, 
and (5) a preliminary model of human left atrial tissue incorporating endocardial, adipose, and 
myocardial tissues. For simplicity, these models will be referred to as the (1) left atrium fiber-1 
model, (2) left atrium fiber-2 model, (3) the non-transmural lesion model, (4) the transmural lesion 
model, and (5) human left atrial model.  The left atrium fiber-1 and left atrium fiber-2 models were 
developed to investigate the influence of OCT-derived, tissue-specific fiber orientation on the 
transmural electrophysiological propagation and corresponding optical signal. The lesion models 
were developed to investigate the behavior of the optical mapping signal within lesions areas. The 
human left atrial model was developed to investigate the influence of different tissue types 
incorporated into the model. 
4.2.2 Imaging Protocol 
Volumetric OCT image sets were acquired from the tissue samples, ex vivo. The tissue samples 
for the left atrium fiber-1, left atrium fiber-2, and human left atrial models were imaged using the 
commercial spectral domain OCT system, TELESTO (Thorlabs GmbH, Dachau, Germany). The 
TELESTO OCT system has a 15 μm and 6.5 μm lateral and axial resolution, respectively, and a 
2.51 mm imaging depth in air. The left atrium fiber-1 dataset was acquired from the epicardial 
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side, while the left atrium fiber-2 and human left atrial dataset was acquired from the endocardial 
side. For the lesion models, two right atrial tissues were first ablated on the endocardial surfaces 
using the commercial RFA system, Stockert 70 (Biosense Webster, Diamond Bar, CA). The image 
sets for the RF ablated tissues were then acquired from the endocardial side using a custom-built 
ultrahigh resolution OCT system, with 5.52 μm and 2.72 μm lateral and axial resolution, 
respectively, and 1.78 mm imaging depth in air [119]. This OCT system was used for imaging the 
ablated tissues because the TELESTO system did not capture the birefringence artifact that could 
be used to detect the ablation lesion in the OCT images.  
Multiple overlapping image volumes were acquired to cover larger regions of tissue for the 
left atrium fiber-2 and lesion models. When necessary, the overlapping image volumes were 
histogram matched to equalize the contrast between separate volumes and stitched together 
manually. Consecutive stitched B-scans were averaged by 3 to improve the visualization of tissue 
features. When necessary, stitched image volumes were downsampled by 3 to reduce the 
computational load during image processing. Trichrome histology and triphenyltetrazolium 
chloride (TTC) staining were carried out on the ablated tissue samples to reveal lesion 
characteristics beyond the sampling depth of the OCT system. Figure 4.1 shows the OCT image 
volumes used to inform the left atrium fiber-1, non-transmural, transmural lesion, and human left 
atrial models, displaying the tissue geometry of the data. For the left atrium fiber-2 data, the entire 
thickness of the tissue was not within the OCT system’s imaging depth and fiber orientation could 
only be observed within a limited region of myocardium underneath the endocardial surface. 
Therefore, the tissue geometry was not included in the left atrium fiber-2 model and only an 




Figure 4.1. OCT imaging of atrial tissues. A, Swine left atrial tissue OCT image volume for the left atrium fiber-1 
model. B, Human left atrial OCT image volume for the human left atrial model. C, Swine right atrial tissue OCT 
image volume with a non-transmural lesion for the non-transmural lesion model. D, Swine right atrial tissue OCT 
image volume with a transmural lesion for the transmural lesion model. 
4.2.3 Image Processing 
Image processing to extract the fiber orientation, tissue geometry, lesion location, and different 
tissue types from the OCT volumetric data was implemented in MATLAB (The MathWorks, 
Natick, MA) or carried out manually using IMOD [138]. 
4.2.3.1 Fiber Orientation Extraction 
Full details of the fiber orientation extraction algorithm have been described previously [95], but 
will be briefly summarized here. Fiber orientation in three dimensions was extracted from fresh 
tissue samples, without optical clearing. We used an automated algorithm that first detected the 
fiber angles in the en face plane and then projected them to 3D based on the detected tissue surface 
orientation. Identification of the fiber angles in the en face images was carried out by determining 
the dominant gradient within small sub-regions spanning each en face image. Afterwards, the 
tissue surface was detected from the OCT B-scans, and for each voxel, the en face fiber angle was 
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projected onto a plane parallel to the tissue surface. The fiber orientation data was median filtered 
by a 3 x 3 kernel to smooth the angles prior to fitting to the models.  
4.2.3.2 Extraction of Tissue Geometry 
The surfaces of the cardiac tissues were detected semi-automatically from the OCT B-scans to 
extract the tissue geometry. Surface detection consisted of image smoothing to reduce the effect 
of speckle noise, and then detection of the maximum gradient magnitude in the axial direction. 
Filtering parameters were tuned manually between datasets or different tissue regions due to 
varying image quality caused by saturation artifacts, distance of the varying tissue topology from 
the imaging surface, use of different imaging systems, or image stitching artifacts. The details of 
the tissue geometry detection are described for each dataset below. 
For the left atrium fiber-1 dataset, to detect the upper, epicardial surface, a 10 x 10 median 
filter was applied to smooth speckle noise, before the maximum magnitude of the gradient in the 
axial direction was detected. To detect the lower, endocardial surface, the upper tissue surface was 
first cropped from the image volume. A 20 x 20 median filter and morphological opening with a 
disk-shaped structuring element of radius 15 were applied to smooth noise. The image was then 
thresholded, and morphological closing on the binary image was applied with a disk-shaped 
structuring element of radius 15 to close gaps in the detected surface. The minimum magnitude of 
the gradient in the axial dimension was detected. For the left atrium fiber-2 data set, the dataset 
was first downsampled by 3. To smooth speckle noise, a 10 x 10 median filter was applied. The 
maximum of the gradient magnitude in the axial direction was detected. A 15 x 15 median filter 
was applied to the detected surface to smooth remaining errors. 
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For the non-transmural lesion dataset, a 20 x 20 median filter was applied to smooth speckle 
noise, and morphological opening with a 30 x 50 rectangular structuring element was applied to 
minimize vertical streak-like saturation artifacts. The gradient magnitude was computed. The 
background signal of the OCT image and blank regions induced by stitching created areas of high 
gradient magnitude that interfered with the detection of the tissue surface. These areas were 
removed after calculation of the gradient magnitude by the following steps. First, a 10 x 10 average 
filter to the original image was applied and the image was thresholded. A dilation of the resulting 
binary image, with a disk-shaped structuring element of radius 20, was applied to create a binary 
mask that was zero over the erroneous boundaries. The gradient magnitude matrix was multiplied 
by this binary mask. Afterwards, the gradient magnitude was thresholded and detected. The 
detected surface from each B-scan was median filtered with a kernel size of 15 to smooth the 
resulting surface. For the transmural lesion dataset, the dataset was downsampled by 3. A 5 x 5 
median filter was applied. The maximum axial gradient magnitude was detected after removal of 
erroneous areas of high gradient magnitude in the axial direction caused by stitching, with an 
equivalent procedure as described above for the non-transmural lesion dataset. The detected 
surface was median filtered with a 15 x 15 kernel size. For the ablated tissue data, the epicardial 
surface was outside of the OCT system’s imaging depth. Therefore, a flat bottom surface for the 
ablated tissue data was assumed. The maximum thicknesses of the ablated tissues were 
approximated from histology or white light images of the gross specimen cross-section. 
For the human left atrial dataset, the tissue surface and endocardial, myocardial and adipose 
tissue regions were segmented manually in IMOD [138] from the B-scans. A binary mask was 
generated for each different tissue type. The lower boundary of the endocardium was determined 
based on the high contrast between the high intensity endocardium and underlying, low intensity 
87 
 
myocardium. The presence of adipose was determined by a brightly spotted or “honeycomb” 
pattern, typically with a background of decreased intensity than surrounding myocardium. A 
representative segmented B-scan is given in Figure 4.2. Because the epicardial surface could not 
be seen in the volume given the imaging depth of the OCT system, a tissue thickness of 1.5 mm 
was estimated from histology. 
 
Figure 4.2. Tissue segmentation. A, OCT B-scan from the human left atrial dataset. B, Segmented B-scan 
corresponding to A. 
The resulting, combined adipose and endocardial thickness for the imaged sample is given in 
Figure 4.3, revealing the thickest regions of adipose and endocardium in the lower right corner. 
 
Figure 4.3. Extracted adipose and collagen thickness map in the human left atrium OCT image volume. Scale bar 
indicates 1 mm. 
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4.2.3.3 Extraction of Ablation Lesion Region 
The boundaries of the ablation lesions were identified by the appearance of the birefringence 
artifact for the non-transmural lesion, and by changes in the tissue features as visualized by OCT 
for the transmural lesion. The appearance of the non-transmural lesion and the birefringence 
artifact seen in OCT is shown in Figure 4.4. A method based on that described in [115] was used 
to detect the lesion boundaries for the non-transmural lesion. To detect the birefringence artifact, 
a region of interest up to 50 pixels below the tissue surface was first defined. Within this region, 
the image was then filtered by a 50 x 50 Laplacian of Gaussian (LoG) filter with a standard 
deviation of 1. The maximum was taken from each A-line within the LoG filtered image and the 
1D vector of maximum gradient values was median filtered by 20 to smooth the extracted trend. 
Finally, the maximum gradient values were thresholded to separate regions based on whether the 
birefringence artifact was present or not. This enabled the detection of the boundary of the lesion 
within each B-scan based on the birefringence artifact. In the OCT image volume of the transmural 
lesion, the birefringence artifact could not be seen in this particular dataset. In this case, the 
decreased contrast between the endocardium and myocardium as well as the disappearance of 
collagen fibers within the lesion were used as markers for the boundary of the lesion, as shown in 




Figure 4.4 Visualization of ablation lesions in OCT. A, Representative stitched B-scan from ablated right atrial tissue 
with birefringence artifact. Dotted white lines indicate the boundaries of the lesion as detected by the fall-off of the 
birefringence artifact. B, Corresponding Trichrome histology of ablated right atrial tissue. Purple indicates necrotic 
tissue while red indicates healthy tissue. C, Representative stitched B-scan from ablated right atrial tissue, where the 
ablation lesion can be observed by the loss of collagen fiber structure and decreased contrast between the myocardial 
and endocardial layers. D, Corresponding Trichrome histology. The scale bars indicate 0.5 mm. 
4.2.4 Electrophysiology Simulation 
4.2.4.1 Mesh Generation for Electrophysiology Simulation 
For the left atrium fiber-1, lesion, and human left atrial models, three-dimensional hexahedral 
finite element models corresponding to the tissue geometry were generated from the OCT-derived 
structural data as seen in Figure 4.5. The spatial discretization for all models was Δx = Δy = 0.1 
mm and Δz ≤ 0.1 mm. For the left atrium fiber-1 model, the fiber orientation was fitted to the 
model using the fitting module within Continuity 6, which uses a least-squares fitting approach. 
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For the lesion and human left atrial models, conduction relative to fiber direction was assumed to 
be isotropic as the fiber orientation could not be extracted throughout the tissue, limited by imaging 
depth or interference from the birefringence artifact. For the lesion models, the location of the 
lesions were also fitted to the geometric model via the fitting module in Continuity 6.  
 
Figure 4.5 Finite element, hexahedral models for electrophysiological simulation, generated from OCT data of atrial 
tissues. A, Left atrium fiber-1 model, shown enlarged in B to show fitted fiber orientation superimposed on the model. 
C, Human left atrial model. D, Non-transmural lesion model. E, Transmural lesion model. For the lesion models, the 
fitted ablation lesion region is shown by a color map of assigned diffusivity (D) parameters. 
For the left atrium fiber-2 model, a slab tissue geometry with uniform thickness was assumed, but 
incorporated the fiber orientation data within a 9.8 x 5.3 x 0.35 mm volume of myocardium. This 
volume of myocardium was extracted from the image volume starting 0.47 mm underneath the 
endocardial tissue surface to ensure extraction of information from the myocardium and not the 
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endocardium. Representative images of the extracted fiber orientation data from OCT and the fiber 
orientation fitted to the model are shown in Figure 4.6. Due to the simplistic geometry used, 
interpolation of the fiber data to the nodal locations of the model was deemed sufficient to fit the 
fiber angles to the model.  
 
Figure 4.6 Left atrium fiber-2 slab model incorporating fitted fiber orientation as extracted from a 9.8 x 5.3 x 0.35 mm 
volume of myocardium imaged by OCT. En face OCT images with superimposed, extracted fiber angles at depths of 
A, 0.47 mm and C, 0.82 mm from the tissue surface. Corresponding fiber fields from A and C are shown fitted to the 
model in B and D, respectively. 
To investigate the influence of detailed OCT-derived fiber orientation, two simplified variants of 
the left atrium fiber-1 and left atrium fiber-2 models were developed with less fiber complexity. 
First, the left atrium fiber-1 and left atrium fiber-2 models were developed without depth-resolved 
changes in fiber orientation, hereafter called transmurally uniform fiber orientation. For these 
models, the fiber orientation in the uppermost layer of elements on the model’s stimulated surface 
was assigned to all layers underneath, thus retaining the spatial fiber orientation heterogeneity in 
the lateral dimensions but creating homogeneous fiber orientation transmurally. Second, the left 
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atrium fiber-1 and left atrium fiber-2 models were simplified to a uniform fiber orientation. To 
generate uniform fiber orientation, all fiber angles were aligned to the y-axis in the left atrium-1 
model, and to the x-axis in the left atrium-2 model. This was based on which axis was closer to 
the dominant fiber orientation direction within each model. Additionally, to investigate the effect 
of tissue geometry on the electrical and optical signals, a uniform thickness model was developed 
with the same lateral dimensions as the left atrium fiber-1 model and with a uniform thickness 
equal to the average thickness of the left atrium fiber-1 model. 
4.2.4.2 Electrophysiology Model and Simulation Parameters 
For the left atrium fiber-1 and left atrium fiber-2 models, including their variants, anisotropic 
diffusivity was assigned such that the ratio of the longitudinal to the transverse conduction velocity 
was about 1.8, based on prior literature [16, 163]. For the ablated tissue models, isotropic 
conduction was assigned. The longitudinal conduction velocity was adjusted to 0.75 m/s [164] 
with diffusivity set to 0.1331 mm2/ms. The transverse conduction velocity was adjusted to 0.42 
m/s with diffusivity set to 0.0411 mm2/ms. For isotropic conduction, a conduction velocity of 0.75 
m/s was used. For the ablated tissue regions, the diffusivity and Fenton Karma ionic model 
excitability parameter, gfi, were reduced to a minimum of ~0.1% in the lesion region to induce the 
non-conducting property of the lesion. For the human left atrial model, the conduction was 
isotropic and set to a velocity of 0.65 m/s, corresponding to a diffusivity of 0.1 mm2/ms. The 
adipose and endocardium regions were modeled by decreasing the diffusivity and ionic excitability 
of the tissue to about 1/7th to 1/10th of the myocardium. To investigate the influence of different 
tissue electrophysiological properties, a simulation was run with the human left atrial model having 
conduction parameters of myocardium homogeneously throughout the model. For all 
electrophysiology simulations, point stimulation was applied on the surface of the models. 
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4.2.5 Light Scattering Simulation 
4.2.5.1 Mesh Generation for Light Scattering Simulation 
The tetrahedral meshes are shown in Figure 4.7. The refractive index of atrial myocardium was set 
to 1.4, or 1.46 if within the ablation lesion region to approximate structural changes such as 
increased collagen content [165, 166]. The refractive index of adipose tissue was set to 1.467, and 
the refractive index of the endocardium was set to 1.5, approximated from literature. [167-169] 
The mean element edge lengths for the swine left atrium fiber and uniform thickness models were 
about 0.06 mm, while the mean element edge length for the non-transmural and transmural lesion 
models were about 0.09 mm and 0.07 mm respectively. The mean element edge length for the 
human left atrial model was 0.06 mm. 
 
Figure 4.7 Tetrahedral models for optical simulation. A, Left atrium fiber-1 model. B, Non-transmural lesion model. 
C, Transmural lesion model. D, Human left atrial model. 
4.2.5.2 Simulation of Tissue Illumination 
The excitation wavelength, 488 nm, was chosen to match the wavelength of light used to excite 
the commonly used voltage-sensitive fluorescent dye, Di-4-ANEPPS. The optical parameters 
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(absorption coefficient μa, scattering coefficient μs, and anisotropy coefficient, g) used in the 
models for 488 nm are shown in Table 4.1. An approximation of the optical parameters of swine 
ablated and un-ablated tissue were obtained experimentally by diffuse reflectance measurements 
of swine atrial tissue samples and an inverse Monte Carlo procedure as described in a prior study 
[170]. The human myocardial, adipose, and endocardial tissue optical properties were 
approximated from literature. [167, 171, 172] To investigate the change in excitation photon 
density distribution caused by the lesion optical properties, an illumination simulation was also 
run for the non-transmural lesion model with the entirety of the model having the optical 
parameters of un-ablated tissue only. 
Table 4.1 Optical Properties of Tissue Models at Excitation Wavelength 488 nm 
Tissue Type μa (mm-1) μs (mm-1) g 
Swine Myocardium 0.62 17.2 0.95 
Swine Ablation Lesion 0.68 19.2 0.95 
Human Myocardium 0.52 23.0 0.94 
Human Adipose 0.16 14.1 0.98 
Human Endocardium 0.11 93.5 0.8 
 
4.2.5.3 Simulation of Fluorescence Emission 
The emission wavelength, 669 nm, was chosen to match the wavelength of light commonly 
measured with the voltage-sensitive fluorescent dye, Di-4-ANEPPS. The optical parameters used 
in the models for 669 nm are shown in Table 4.2 and were obtained with the same methods used 
to obtain the optical properties at the excitation wavelength.  
Table 4.2 Optical Properties of Tissue Models at Emission Wavelength 669 nm 
Tissue Type μa (mm-1) μs (mm-1) g 
Swine Myocardium 0.075 13.6 0.95 
Swine Ablation Lesion 0.104 16.2 0.95 
Human Myocardium 0.1 21.8 0.96 
Human Adipose 0.12 63.0 0.978 
Human Endocardium 0.02 11.3 0.85 
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4.2.6 Data Analysis and Computational Resources 
Activation time, transmural activation time, action potential upstroke duration, and fractional level 
of maximum upstroke velocity were computed to quantify the simulated electrical and optical 
action potentials. Activation time was computed as the time of the upstroke’s maximal derivative 
[173]. Total activation time was defined as the latest activation time. Transmural activation time 
was defined as the difference between the activation times on the stimulated surface of the model 
from the activation times on the opposing surface of the model. Specifically, the transmural 
activation time at a particular x-y coordinate was computed by subtracting the activation time at 
the x-y point on the stimulated surface of the model from the activation time at the point on the 
opposite surface of the model with the same x-y coordinates. Action potential duration was 
calculated as the time between 10% and 90% depolarization. The action potential upstroke 
duration is reported as mean (± 1 SD). The fractional level of maximum optical upstroke velocity, 
Vf*, is a parameter that has been established in past optical mapping studies [145, 153], where it 
was used to describe changes in optical upstroke morphology with respect to direction of electrical 
propagation. The parameter quantifies the time of the maximum upstroke velocity and ranges from 
0 to 1. A higher value of Vf* indicates the location of the maximum upstroke velocity is near the 
apex of the upstroke, while a lower value indicates the maximum upstroke velocity is near the foot 
of the upstroke [145, 153]. Vf* was detected within the 10% to 90% depolarization interval. To 
compute the derivatives of the upstroke, the upstrokes were first interpolated with piecewise cubic 
polynomials to a discretization of about 6.5 μs, before a first order, one-sided finite difference 
method was applied. Simulations were run on Columbia University’s Yeti Shared High 





4.3.1 Electrophysiology Results 
4.3.1.1 Fiber Orientation Models 
Electrical activation maps, transmural electrical activation maps, and differences between 
transmural electrical activation maps for the left atrium fiber-1 and left atrium fiber-2 models are 
given in Figure 4.8. The difference in surface electrical activation pattern with tissue-specific fiber 
orientation compared to activation with uniform fiber orientation is apparent when comparing 
Figure 4.8A to Figure 4.8C, and Figure 4.8I to Figure 4.8K. As expected, the surface activation 
between the tissue-specific and transmurally uniform fiber orientation models were nearly 
identical, as seen Figure 4.8A-B and Figure 4.8I-J. Total activation time tended to increase with 
increasing complexity of fiber orientation. The left atrium fiber-1 model had a total activation time 
of 7.7 ms with tissue-specific fitted fiber orientation, 7.6 ms with transmurally uniform fiber 
orientation, and 7.3 ms with uniform fiber orientation. For the left atrium fiber-2 model, the total 
activation time of the model with tissue-specific fitted fiber orientation and transmurally uniform 
fiber orientation were the same, with a total activation time of 12.0 ms. The total activation time 
of the left atrium fiber-2 model with uniform fiber orientation was 11.2 ms. For the left atrium 
fiber-1 model, subtle differences can be observed between the transmural activation maps of the 
model’s variants, as shown in Figure 4.8D-F. To more clearly show these differences, Figure 4.8G-
H show the transmural activation times of the simplified fiber models subtracted from the 
transmural activation times of the tissue-specific fiber model, showing differences up to about 0.4 
ms. For the left atrium fiber-2 model, the transmural activation times were low due to the thinness 
of the mesh. However, the tissue-specific fiber orientation induced non-zero transmural activation 
time up to about 0.2 ms as seen in Figure 4.8L, while the transmurally uniform and uniform fiber 
orientation models had zero transmural activation time throughout the majority of the model, as 
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shown in Figure 4.8M-N. Accordingly, the difference maps of Figure 4.8O-P closely resemble the 
transmural activation time map from the fully fitted left atrium fiber-2 model of Figure 4.8L.  
 
Figure 4.8 Electrical activation maps, transmural electrical activation maps, and differences between transmural 
electrical activation maps for the left atrium fiber-1 model, left atrium fiber-2 model, and their variants. Isochronal 
activation maps of the stimulated surface for left atrium fiber-1 model with A, tissue-specific fitted fiber orientation, 
B, transmurally uniform fiber orientation, and C, uniform fiber orientation. Black isolines indicate 0.5 ms intervals. 
Transmural activation maps for the left atrium fiber-1 model with D, tissue-specific fitted fiber orientation, E, 
transmurally uniform fiber orientation, and F, uniform fiber orientation. Difference in transmural activation times 
between the left atrium fiber-1 model with tissue-specific fiber orientation and G, transmurally uniform fiber 
orientation and H, uniform fiber orientation. Isochronal activation maps of the stimulated surface for left atrium fiber-
2 model with I, tissue-specific fitted fiber orientation, J, transmurally uniform fiber orientation, and K, uniform fiber 
orientation. Black isolines indicate 0.5 ms intervals. Transmural activation maps for the left atrium fiber-2 model with 
L, tissue-specific fitted fiber orientation, M, transmurally uniform fiber orientation, and N, uniform fiber orientation. 
Difference in transmural activation time between the left atrium fiber-2 model with tissue-specific fiber orientation 
and with O, transmurally uniform fiber orientation and P, uniform fiber orientation. 
4.3.1.2 Human Left Atrial Model 
Electrical activation time maps of the surface opposing the stimulated surface in the human left 
atrial model are given in Figure 4.9. Comparing the results from the model containing 
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heterogeneous tissue types, given in Figure 4.9A, to the results from the model containing 
homogeneous tissue types, as shown in Figure 4.9B, it can be seen that the activation time is less 
uniform in the heterogeneous model, no longer having a simple ellipsoidal shape radiating from 
the stimulus point. Additionally, the activation of the entire model took longer in the model with 
heterogeneous endocardium, myocardium, and adipose parameters, with the total activation time 
being 19.6 ms for the heterogeneous model and 11.2 ms for the homogeneous model. The 
difference between the activation times shown in Figure 4.9A and B is given in Figure 4.9C. The 
most difference occurred in the bottom-right corner, where there was significant adipose and 
endocardial thickness. 
 
Figure 4.9 Electrical activation time maps for the human left atrial model with A, myocardium, endocardium, and 
adipose tissue properties, and B, homogeneous myocardium properties, as seen from the stimulated surface of the 
model. C, Difference between electrical activation time between B and A. 
4.3.2 Illumination Results 
4.3.2.1 Fiber Orientation Models 
The distribution of excitation photon density was slightly different between the left atrium fiber-1 
model containing tissue geometry and the uniform thickness model. In the epicardial distributions 
of excitation photon density as shown in Figure 4.10A and Figure 4.10B, the photon density 
distribution in the tissue-specific model was greater towards the left region of the model while it 
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was more symmetric in the uniform thickness model. In transmural cross-sections, the illuminating 
light was not fully attenuated through the thin tissues upon reaching the endocardial surface of the 
pictured cross-sections, as illustrated in Figure 4.10C and D. 
 
Figure 4.10 Excitation photon density on the left atrium fiber-1 model and uniform thickness model. The photon 
density is normalized with respect to the maximum density in each model, exempting values on the lateral boundaries 
of the models due to boundary effects. A, Epicardial map and C, cross-sectional view at y = 1.8 mm, on the left atrium 
fiber-1 model. B, Epicardial map and D, cross-sectional view at y = 1.8 mm, on the uniform thickness model. The 
epicardial map color values are shown starting from 95% of the maximum photon density to enhance the contrast of 
the surface photon density distribution. Crosshairs on the epicardial maps depict the center of the surface. 
4.3.2.2 Lesion Models 
For the non-transmural lesion model, the excitation photon scattering was simulated with and 
without the lesion region to determine the effect of the lesion optical properties on the penetration 
of excitation light. The difference between the excitation photon density within the model with 
and without the lesion, scaled to the maximum excitation photon density in the model without the 
lesion, is shown in Figure 4.11. The inclusion of the lesion region, which had increased scattering 
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and absorption compared to un-ablated tissue, caused a slight increase in the excitation photon 
density close to the ablated tissue surface, and a decrease throughout the rest of the lesion area. 
 
Figure 4.11 Cross-sectional view of the difference between the excitation photon density in the non-transmural lesion 
model with and without the lesion region included, at y = 1.5 mm. The difference is scaled to the maximum excitation 
photon density in the model without the lesion. 
4.3.2.3 Human Left Atrial Model 
A representative view of the excitation photon density in the human left atrial model after 
illumination is provided in Figure 4.12A, with the corresponding distribution of tissue types shown 
in Figure 4.12B for comparison. Most of the excitation photon density was concentrated within 
the endocardial and adipose tissue layers, with a decrease in excitation photon density at the 




Figure 4.12 Excitation photon density on the human left atrial model with myocardium, adipose, and endocardium 
parameters. A, Excitation photon density over the model. B, Model showing the distribution of adipose, myocardium 
and endocardium tissues. 
4.3.3 Fluorescent Emission Results 
4.3.3.1 Fiber Orientation Models 
As in the illumination simulation, the optical mapping signal amplitude between the tissue-specific 
left atrium fiber-1 model and the uniform thickness model had different distributions, reflecting 
the influence of the thin tissue geometry. The epicardial maps of the optical mapping signals in 
Figure 4.13A and Figure 4.13B show the asymmetric distribution within the tissue-specific model 
in contrast to the uniform thickness model. In comparison to the tissue thickness map shown in 
Figure 4.13C, the signal amplitude in the tissue-specific model was generally lower within 
approximate regions of thinner tissue and higher around thicker regions. 
 
Figure 4.13 Tissue thickness and optical mapping signal distribution for the left atrium fiber-1 model and uniform 
thickness model. A, Epicardial distribution of the optical mapping signal in the left atrium fiber-1 model, at t = 9 ms. 
B, Epicardial distribution of the optical mapping signal in the uniform thickness model, at t = 9 ms. C, Tissue thickness 
of the left atrium fiber-1 model. The photon density is normalized to the maximum photon density on the top surface 
of the model. 
Optical activation time maps and distributions of the fractional level of maximum upstroke 
velocity Vf* for the left atrium fiber-1 model are shown in Figure 4.14. The trends of optical 
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activation time seen in Figure 4.14A-C correspond to that of the electrical activation times shown 
in Figure 4.8A-C. The fractional level of maximum upstroke velocity is a parameter that has been 
used in prior studies to characterize the correlation between the optical upstroke morphology and 
the angle of propagation of the subsurface electrical wavefront with respect to the tissue surface 
[145, 153]. In agreement with past studies, the values of Vf* increased from the point of 
stimulation. The pattern of Vf* followed the surface activation pattern from the 
electrophysiological simulation. Differences in Vf* up to about 60% were observed between the 
Vf* maps of the tissue-specific fitted fiber model when compared to the Vf* maps of the 
transmurally uniform fiber model or uniform fiber model. These differences were especially 
apparent at the areas where the propagation of the electrical wavefront transitioned from moving 
away from the stimulated surface to an angle moving towards the stimulated surface. Differences 
were minimal at regions where Vf* had reached a maximum. Comparing Figure 4.14G-H to Figure 
4.8G-H, correlation of the differences in Vf* between the different fiber distributions to the 




Figure 4.14 Optical activation and Vf* maps for the left atrium fiber-1 model and its variants. Isochronal optical 
activation maps of the stimulated surface for A, tissue-specific fitted fiber model, B, transmurally uniform fiber model, 
and C, uniform fiber model. Black isolines indicate 0.5 ms intervals. Vf* maps for D, tissue-specific fitted fiber model, 
E, transmurally uniform fiber model, and F, uniform fiber model. Difference in Vf* between tissue-specific fitted fiber 
model and G, transmurally uniform fiber model and H, uniform fiber model. 
Optical upstroke prolongation was observed. For the left atrium fiber-1 model, the electrical 
upstroke duration was 1.1 (± 0.3) ms, while the optical upstroke duration was 3.1 (± 0.3) ms.  
4.3.3.2 Lesion Models 
 For the lesion models, the blurring of optical signals into regions that were electrically 
inactivated could be observed. As seen within the optical mapping signal snapshots shown in 
Figure 4.15A and B, the minimum normalized optical mapping signal amplitude was higher within 
the transmural lesion. To better understand the relative contribution of fluorescent signal 
throughout the tissue, Figure 4.15C and D show the density of emitted fluorescent photons for the 
same time points as the optical mapping snapshots in a transmural cross-section of the tissue. The 
density of emitted photons is weighted by the distribution of excitation photon density and 
transmembrane potential, and the absence of emitted photons within the electrically inactivated 
lesion area can be seen by the darkened regions near the upper tissue surface. The density of 
emitted photons can also be seen to decrease with depth due to the decay of excitation intensity. 
As seen in Figure 4.15C, electrical propagation occurring underneath the non-transmural lesion 





Figure 4.15 Optical mapping results in the lesion models. A, Endocardial map of optical mapping signal distribution 
and C, transmural cross-section of emitted fluorescent photon density distribution at y = 1.5 mm, at t = 23 ms, in the 
non-transmural lesion model. B, Endocardial map of optical mapping signal distribution and D, transmural cross-
section of emitted fluorescent photon density distribution at y = 1.2 mm, at t = 21 ms, in the transmural lesion model. 
The optical mapping signal photon density is normalized to the maximum photon density on the top surfaces of the 
models. The emitted fluorescent photon density distribution is normalized to the maximum photon density within the 
cross-section. Black arrows indicate the location of the transmural cross-sections along the y axis. 
4.3.3.3 Human Left Atrial Model 
Snapshots of the optical mapping signal, and corresponding electrical signal, on the heterogeneous 
and homogeneous human left atrial model are given in Figure 4.16. Blurring in the optical mapping 
signal significantly masked the heterogeneity of the electrical signal distribution. Comparing 
Figure 4.16A to Figure 4.16B, the distribution of the transmembrane potential is more non-uniform 
in the heterogeneous model shown in Figure 4.16A. However, in the corresponding optical 
mapping signal in Figure 4.16C, the non-uniformity is smoothed out to a similar ellipsoidal 




Figure 4.16 Snapshots of electrical and optical mapping signals as seen from the surface opposing the stimulated 
surface of the model. A, Normalized transmembrane potential (Vm) from the model with myocardium, collagen, and 
adipose properties, at t = 12 ms. B, Vm from model with only myocardial properties, at t = 9 ms. C, Optical mapping 
signal from model with myocardium, collagen, and adipose properties, at t = 12 ms. D, Optical mapping signal from 
model with only myocardial properties, at t = 9 ms. The optical mapping signal distribution is normalized with respect 
to the maximum optical signal in the model at the given time. 
4.4 Discussion 
This study demonstrated the first applications of OCT-derived atrial tissue models for 
electrophysiology and optical mapping simulations. Five different models were developed 
containing tissue structural characteristics extracted from OCT imaging, including tissue 
geometry, fiber orientation, ablated tissue location, and different tissue types. The effects of the 
incorporated tissue structure on the simulated electrical and optical signals were analyzed. Our 
objective for developing tissue-specific atrial models is to facilitate deeper investigation of the 
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relationship between atrial electrophysiological function and detailed tissue-specific structure to 
improve the understanding and treatment of atrial fibrillation. 
4.4.1 Influence of Depth-Resolved Fiber Orientation 
 OCT offers depth-resolved, micrometer-scale information on fiber orientation, which can 
be useful when considering transmural electrophysiological dynamics. Depth-resolved variation 
in fiber orientation led to changes in transmural activation time. This was observed in the left 
atrium fiber-1 and left atrium fiber-2 models by the differences in transmural activation time 
between the tissue-specific fitted fiber orientation models and their simplified fiber variants. With 
recent interest in the difference between epicardial and endocardial electrical activation during 
atrial fibrillation [14], high resolution and depth-resolved fiber orientation information offered by 
OCT may be helpful in understanding arrhythmia dynamics. 
We also investigated the ability of optical mapping signals to reflect such changes in 
electrophysiological transmural activation. Optical mapping simulations and experimental studies 
by Hyatt et al. demonstrated that the subsurface orientation of the propagating electrical wavefront 
with respect to the tissue surface is correlated to the optical upstroke morphology [145]. However, 
it has been demonstrated in anatomic optical mapping models [72, 76] and experiments [153] that 
patterns of electrical propagation and consequently extracted Vf* can become more complex due 
to tissue heterogeneities and fiber orientation. Changes in the surface electrical activation patterns 
due to anisotropic conduction along fibers were reflected in the Vf* maps. As seen within the 
difference maps of Figure 4.14G and H, varying depth-resolved fiber orientation altered the optical 
upstroke distribution and emphasizes the influence of structure on electrophysiological 
propagation and subsequently optical mapping signal characteristics. These differences appeared 
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to be more significant closer to the stimulus point and particularly as the wavefront transitioned 
from traveling away to traveling towards the tissue surface. 
4.4.2 Ablation Lesion Geometry and Fluorescence 
In addition to incorporation of fiber orientation, we were also able to build OCT-derived 
tissue-specific models of ablation lesions and simulate optical mapping in the models to observe 
the interaction between the electrical and optical signals and the lesions. The blurring of the optical 
signal compared to the electrical signal around the boundaries of the lesion was observed. In 
particular, the minimum, normalized optical signal intensity was higher in the transmural lesion 
within our simulations. There was a low contribution to the optical mapping signal from the 
electrical propagation occurring underneath the non-transmural lesion due to the decay of 
excitation intensity. Thus, the lateral scattering from the regions surrounding the lesion contributed 
more significantly to the optical mapping signal. Due to the smaller diameter of the transmural 
lesion, this can explain the higher optical signal intensity within the transmural lesion and 
emphasizes the need to be aware of the origin of the optical signal when relating lesion depth to 
optical signal amplitude. Modeling of light propagation in tissue-specific conditions could assist 
in the development of optical techniques to monitor lesion formation, such as those using 
endogenous nicotinamide adenine dinucleotide (NADH) fluorescence [174] or near infrared-
spectroscopy [170]. Tissue-specific ablation models could be used to evaluate and analyze the 
behavior of the optical techniques in a realistic model containing heterogeneities that would 
otherwise complicate use of the techniques.   
4.4.3 Influence of Heterogeneous Tissue Types 
Finally, we generated a human atrial tissue model containing heterogeneous tissue types 
including endocardium and adipose tissue. It was shown that the inclusion of these different tissue 
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types led to non-uniformity of conduction and slowing of activation time. Alteration in conduction 
properties caused by heterogeneous tissue composition could be associated with arrhythmic 
dynamics, and the structural detail provided by OCT could lead to more realistic models of 
electrical propagation within the atria and provide valuable insights on structure-function 
relationships. Furthermore, it was shown that the characteristic blurring of the optical mapping 
signal obscures details of the heterogeneous electrical propagation. Therefore, optical mapping 
models of heterogeneous tissues could better define the interpretation of optical mapping results. 
4.4.4 Limitations and Future Work 
 This study demonstrated a framework for developing OCT-derived atrial tissue models and 
showed influences of OCT-derived structural features on the electrophysiological and optical 
signals. However, a larger imaged tissue region would be helpful to enable a more thorough 
investigation of arrhythmia dynamics in large animals or human hearts and the influences on 
electrical and optical signals with respect to detailed structural information. The lateral field of 
view can be enlarged by stitching a larger number of OCT volumes, while the imaging depth of 
OCT could be expanded by imaging and stitching both sides of the tissue, imaging thick serial 
sections of the tissue, or through optical clearing combined with imaging by a swept-source (SS)-
OCT system. SS-OCT systems offer higher imaging depths due to the use of longer wavelength 
light sources and could enable high-resolution imaging of deeper tissue structure without 
complications of image registration or potential artifacts from sectioning. However, future work 
remains in obtaining the best balance between tissue contrast and depth penetration with optical 
clearing. 
Limitations of this study include lack of experimental validation, which would require 
registration of optical mapping data from the tissue to its OCT-derived model. Although the optical 
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mapping signal characteristics observed within this study, such as the optical signal blurring and 
morphology changes, are in line with prior experimental and modeling results, direct experimental 
comparison would be necessary to fully validate tissue-specific effects and parameters. In this 
study, electrophysiological and optical parameters were informed by literature. Additionally, while 
optical absorption and scattering parameters were obtained from a swine tissue sample through an 
inverse Monte Carlo method, the reduced scattering coefficient, as opposed to the scattering 
coefficient, was obtained. The scattering coefficient was estimated from the reduced scattering 
coefficient and an approximate value of the anisotropy coefficient, near the range found in prior 
literature [172], due to lack of existing information on swine atrial optical properties. The tissue 
was also not stained with voltage-sensitive dye when the optical parameters were measured. With 
regards to lesion imaging and modeling, OCT was unable to detect the lesion depth. Furthermore, 
changes in endocardial and myocardial contrast as the marker for lesion boundaries may vary in 
alignment between the lesion necrotic core and border zone. Establishing a more accurate 
framework for electrophysiological and optical modeling of the lesion in detail is a focus for future 
investigation. Lastly, due to the different algorithms used for generation of the hexahedral and 
tetrahedral meshes and different simulation approaches of the electrical and light propagation, 
registration between the two models have slight differences, primarily in the lesion model which 
has a smoothly transitioning lesion boundary in the electrophysiological model but a sharp 
boundary within the photon scattering model. 
 The next steps for OCT-derived optical mapping atrial models include the modeling of 
larger tissue regions, including the incorporation of more varying tissue types such as fibrosis, and 
ultimately working towards a comprehensive visualization and model of the whole atria utilizing 
stitched OCT image volumes. Future studies will also include further study of OCT-derived lesion 
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models, including simulation of electrical propagation with multiple ablation lesions of varying 
sizes and configurations, and inclusion of transmural myofiber orientation to allow a more detailed 
understanding of varying electrophysiological conduction and block around ablated areas in 
different conditions. In the future, OCT imaging could also be registered with MRI or CT-derived 
data for a multi-modality imaging approach. 
4.5 Conclusion 
OCT-derived atrial models have the potential to provide additional, high resolution, tissue-specific 
structural detail in simulations of cardiac electrophysiology and optical mapping. This study has 
demonstrated the framework for OCT-derived tissue-specific, optical mapping models of the atria, 
which has the potential to enable a more direct comparison between simulation and experimental 
results. Optical mapping models of atrial tissue as derived from OCT have the potential to guide 





Chapter 5 Summary and Future Work 
5.1 Conclusion 
The underlying principles of atrial fibrillation remain incompletely understood, and it is clear 
from years of research that the mechanisms of this highly prevalent arrhythmia are heterogeneous, 
complex, and patient-specific. Detailed understanding of the tissue structure that contributes to 
atrial fibrillation dynamics can improve understanding of abnormal electrophysiological patterns 
and ultimately inform better treatments. Within this work, we explored the use of OCT in 
identifying tissue microstructure of the entire human left atrium for the first time, and established 
a framework for applying OCT to tissue-specific models for studying cardiac electrophysiology.  
 In Chapter 2, we studied comprehensive OCT imaging of human left atrial tissue within 
the context of human left atrial anatomy, as well as discussed the whole human heart OCT 
imaging atlas. Large, centimeter-scale OCT imaging maps were registered to a model of the 
human left atrium to correlate imaging features to left atrial geometry. Imaging features for 
various tissue types within the human left atrium were established through correlation to 
Trichrome histology, including endocardium, myointimal thickening, collagen fibers, adipose 
tissue, and venous media. The distribution of OCT-imaged adipose tissue and fiber orientation 
through human left atria, as well as the transition of myocardial sleeves within the pulmonary 
veins to regions of only venous media and adventitia, were identified. Notably, the ability of OCT 
to identify specific densities and distributions of collagen fibers within the myocardium was also 
demonstrated, showing promise for OCT to provide an improved understanding of the interaction 
between different types of fibrotic regions and electrophysiology. The data from this study enable 
an improved understanding of the microstructure of human left atrial tissue, and could guide the 
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application of real-time, structural substrate identification using OCT-integrated catheters or ex 
vivo, cardiac OCT imaging studies. More generally, the human cardiac OCT atlas could also guide 
OCT applications to the study of cardiac disease throughout the human heart. 
 In Chapter 3, a modeling protocol for the development OCT-based tissue-specific models 
of atrial tissue was established. Electrophysiological simulations using a hexahedral, finite 
element modeling scheme were combined with a tetrahedral-based, Monte Carlo photon 
scattering model to simulate optical mapping in tissue-specific models of heterogeneous tissue 
structure. Tissue-specific features such as myofiber orientation, ablation lesions, and varying 
tissue types could be extracted from the OCT image volumes and incorporated into the finite 
element models through fitting and interpolation. This workflow provides a basis for OCT-
derived optical mapping models. 
 In Chapter 4, applications of OCT-informed models for optical mapping simulation were 
demonstrated. Five different models were generated: two models containing OCT-extracted 
myofiber orientation, two models containing ablation lesions, and one model containing 
heterogeneous tissue types. Changes in transmural activation time were seen when incorporating 
tissue-specific, depth-resolved fiber orientation, which translated into changes in the distribution 
of the morphology of the correlated optical mapping upstrokes. Modeling tissue-specific ablation 
lesions enabled a better understanding of the distribution of fluorescent signals corresponding to 
non-transmural and transmural lesions with respect to lesion geometry as well as the scattering 
and absorption of illumination and fluorescent light. Finally, we were able to observe that the 
inherent blurring of optical mapping signals obscured non-uniformity in the electrophysiological 
signal in the presence of heterogeneous tissue microstructure. It is possible that with the 
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combination of optical mapping models derived from tissue-specific OCT images, better 
understanding of the relationships between tissue structure and function could be made. 
5.2 Future Work 
Work remains in relating OCT-derived imaging of atrial tissue structure to the understanding of 
arrhythmia.  Future work of particular interest include correlations of imaging data to disease, 
augmentations in the imaging protocol to provide increased depth penetration, more advanced 
image processing to maximize the utility of the obtained imaging data, more comprehensive OCT-
informed cardiac models, and explorations in vivo to further establish the applicability of 
structural substrate characterization during ablation using OCT-integrated catheters. 
5.2.1 Correlation of Imaging Data to Disease 
The large volume of OCT imaging data in the human left atrium and across human hearts 
accumulated within this study provides a large amount of information about cardiac tissue structure 
that may be able to be correlated to disease. As OCT is able to provide detailed information about 
tissue structure unable to be previously captured by other imaging modalities; such as endocardial 
thickness, fibrosis organization and density, myointimal thickening, and intra-myocardial adipose 
infiltrations; identifying any correlations with these OCT-identified tissue structures with cardiac 
pathologies may offer new insights on disease mechanisms.  
5.2.2 Increasing Imaging Depth 
Although the work carried out within this study was done without processing the tissue to better 
understand the usefulness of OCT in vivo, the high-resolution imaging provided by OCT can also 
be used as an alternative to histology, which may be expensive and time-consuming. However, 
OCT is limited by its penetration depth, which practically provides useful imaging data about 1 
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mm into the tissue. This can be circumvented through serial sectioning methods as well as optical 
clearing, which have both been successfully applied in small animal hearts to improve imaging 
depth. [94, 97] As a preliminary example, Figure 5.1 shows a B-scan of swine left atrial tissue 
optically cleared by a 2,2’-thiodiethanol (TDE)-based aqueous solution [175] and imaged by a 
custom-built SS-OCT system [176], showing tissue contrast throughout the tissue thickness of 
about 2 mm. Combined with increased optical depth penetration induced by optical clearing, 
imaging with an SS-OCT system could enable high-resolution imaging of deeper tissue structure. 
 
Figure 5.1. Representative SS-OCT B-scan from a swine left atrial sample optically cleared by a TDE-based 
aqueous solution. Scale bar indicates 0.5 mm. 
5.2.3 Automatic Tissue Classification 
Due to the large volume of data collected by OCT over the whole human left atrium, automatic 
image processing algorithms would assist in interpretation of the data and in providing more 
quantitative measurements. While work in automated tissue classification of human left atrial 
tissue has been developed and tested [118], it is limited to an assumption of a layered tissue 
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structure. During the work of this thesis, however, initial studies were carried out on the automated 
detection of adipose tissue, fiber orientation, and endocardial thickness. An initial study on the 
detection of adipose tissue within larger imaged regions of human left atrial tissue was conducted 
by adopting an algorithm that was used to identify adipose tissue in breast tissue, shown in Figure 
5.2. [177] The results show promise of being able to automatically detect distributions of tissue 
composition over a widespread area. 
 
Figure 5.2. Automatic detection of adipose tissue in a stitched human left atrial image map. A, En face OCT image, 
shown 0.27 mm from the endocardial surface; B, adipose map with a probability of containing adipose tissue in the 
A-line of each lateral location; (i) OCT B-scan with collagen; (ii) OCT B-scan with adipose tissue; (iii) OCT B-scan 
with a mix of fibrotic myocardium and adipose tissue.  Figs (i-iii) correspond to the white lines shown in A and B.   
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Preliminary results on the detection of endocardial thickness are provided in Figure 5.3, using a 
modified version of the layer detection algorithm described in a prior study. [118] Manual 
measurements by segmentation in IMOD are shown as a comparison. However, due to the highly 
laborious nature of manual measurements, interpolation was carried out across individually 
segmented B-scans, blurring the manual measurements and incurring its own inaccuracies. As 
demonstrated in the figure, the algorithm provides a good approximation of endocardial thickness 
where the endocardial thickness changes drastically. However, limitations remain in accurate 
representation of endocardial thickness from automated segmentation due to the gradual fall-off 
of intensity in regions where the endocardial thickness is beyond the penetration depth of OCT. 
Such ambiguity can cause difficulties in segmentation even with manual measurements. Therefore, 
it is likely that a confidence parameter will need to be incorporated into the algorithm in future 
developments. Detection of tissue composition such as endocardium can also, alternatively, be 




Figure 5.3. Automated endocardial thickness segmentation from an OCT en face image map. A, En face OCT 
image, shown 0.46 mm from the endocardial surface. B, Extracted endocardial thickness map from automated 
algorithm. C, Manually segmented endocardial thickness map. 
Fiber directionality was extracted using a previously described OCT fiber tracking algorithm, 
[137] which captured the overall trend of the fibers. However, further filtering is required to 
remove regions of artifact incurred by areas of thick endocardium. 
 
Figure 5.4. Automated detection fiber orientation. A, En face OCT image of myofiber orientation seen 0.51 mm 
beneath the endocardial surface. B, Fiber orientation extracted using a pixel-wise algorithm. 
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The preliminary results shows great promise, although further work remains in testing the 
robustness of the algorithms over the large OCT dataset comprising the whole human left atrial 
tissue. Additionally, the appropriate processing of new features of interest such as fibrosis 
density and pulmonary sleeve length have not yet been investigated 
5.2.4 Improved Modeling Protocol 
The OCT imaging data was wrapped to a single, representative atrial mesh with minor changes to 
its anatomy. In reality, different left atria are of different sizes and morphology, including varying 
orientation of pulmonary veins. Therefore, for more accurate mapping, it would be useful to obtain 
a personalized mesh of left atrial anatomy for each specimen, such as could be acquired from MRI 
or CT. This would enable more accurate registration, improved interpretation and personalization 
of the tissue structure imaged by OCT. 
Additionally, combined with changes in the imaging protocol to improve imaging depth, 
modeling can be carried out in larger regions of cardiac tissue to better simulate arrhythmia 
dynamics. It is possible that a new modeling scheme would be required to more appropriately 
balance the tradeoff between computational burden and structural detail, as well as optimize model 
properties for tissues that have not before been incorporated in cardiac modeling. It will also be 
necessary to compare the results of the models to real optical mapping data to provide validation 
of the simulated results and extract further conclusions on structure-function relationships. 
5.2.5 OCT-Integrated Catheters 
In an in vivo setting, further challenges will occur due to heart motion, presence of blood, and 
requirements for faster data acquisition. However, OCT-integrated catheters have already been 
developed and tested in vivo, and were shown to be able to identify tissue microstructure such as 
the endocardium and tears within the myocardium, showing great promise towards the goal of 
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OCT-guided ablation procedures [113] Registration of OCT imaging to an anatomical mesh in real 
time, such as is done with current electroanatomic mapping technologies, would also be useful to 
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Optical Coherence Tomography Cardiac Atlas: Interpretation Guidelines  
1. Categories 
(1) Endocardium: Always the uppermost tissue layer. Seen as blue or purple in histology and 
typically is the brightest layer within OCT. Thickness can vary greatly, but can be extremely thin 
in the ventricles. May appear to have multiple layers due to varying compositions of connective 
tissue. 
 
(2) Myocardium: Always below the endocardium (unless endocardial layer is absent). Seen as red 
in histology and is typically a darker grey in OCT. Note that if the endocardium is very thick, the 




(3-6) Fibrotic Myocardium: Myocardium with collagen content. Seen as red myocardium with 
blue collagen in histology. Corresponding OCT features can vary. In some cases, the OCT region 
may contain heterogeneous variations in intensity (like below). In other cases, there may be no 
particular features that look like fibrosis in OCT (i.e. just looks like normal myocardium), but 
regardless should be labeled as fibrosis if histology shows a significant amount of it. If the fibrotic 
region is minor and does not cover the majority of the region, simply label as myocardium. 
 
(7) Adipose: Seen as white in histology, and as a speckled or “honeycomb” pattern in OCT. Note 
that depending on the depth at which adipose tissue is located, adipose tissue may have a clear 
“honeycomb” structure in OCT (top example), or may have a more spotted appearance that 
becomes increasingly vague the deeper in the tissue it is located (bottom examples). The location 
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of adipose seen in OCT may not correspond exactly to that seen in histology, but it should be 
relatively clear to identify adipose in OCT based on its unique texture. 
 
(8) Right-Side Endocardium at Septum 
A lower wall similar to the endocardium seen in certain areas of the left atrium. 
 
(9) Endocardial Scar/Thickening 




(10) Saturation Artifact: Caused by an over-reflective surface. Appears as vertical stripes. 
 
(11) Immersion Lens: A thin line in the OCT image that comes from the lens used during imaging 




(12) Autocorrelation Artifact: Artifact produced by the lens. Always seen at the bottom of the 
image as a smooth grey region. 
 
(13) Reflection Artifact: Area of high reflection caused by water or a wet surface. 
 
(14) Blood Vessel: Circular shape with darker intensity region seen with slightly brighter outline 




2. Example Segmentations and Notes 
(1) Leave regions beyond the penetration depth un-labeled. 
 





(3) If the fibrotic region appears to be beyond the imaging depth, do not label as fibrosis. 
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